<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Pathology-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 57621,
    "choices": [
      {
        "id": 229853,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytomegalovirus</span></span></p>"
      },
      {
        "id": 229854,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus</span></span></p>"
      },
      {
        "id": 229855,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epstein-Barr virus infection</span></span></p>"
      },
      {
        "id": 229856,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HSV</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with anemia and a regular history of blood transfusions since an early age was carrying his daily activities normally. He experiences a mild respiratory infection following which he developed fatigue, severe pallor, and shortness of breath. Which of the following is the likely organism involved? (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q2007294",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669487,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Parvovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The scenario describes a patient with a history of anemia and regular blood transfusions, which suggests an underlying hemolytic anemia, such as thalassemia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Thalassemia</span></strong><span style=\"font-size:12.0pt\"> is a genetic disorder characterized by ineffective erythropoiesis and chronic hemolysis, often requiring frequent blood transfusions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this context, a sudden onset of fatigue, severe pallor, and shortness of breath following a mild respiratory infection is indicative of an aplastic crisis. <strong>Aplastic crisis occurs when there is a sudden halt in red blood cell production due to the infection of erythroid progenitor cells in the bone marrow by Parvovirus B19.</strong> This virus selectively targets and destroys these cells, which are already in high turnover due to the compensatory response to chronic hemolysis in conditions like thalassemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cytomegalovirus:</span></strong><span style=\"font-size:12.0pt\"> This virus can cause systemic infections, especially in immunocompromised patients, but it does not specifically target red blood cell progenitors or cause aplastic crisis in hemolytic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Epstein-Barr virus infection:</span></strong><span style=\"font-size:12.0pt\"> Epstein-Barr virus (EBV) typically causes infectious mononucleosis and can affect various cell types but is not associated with aplastic crises or specific targeting of erythroid progenitors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. HSV (Herpes Simplex Virus):</span></strong><span style=\"font-size:12.0pt\"> HSV primarily causes mucocutaneous infections and does not affect erythroid progenitor cells, making it an unlikely cause of an aplastic crisis in a patient with underlying hemolytic anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19 is the most common cause of aplastic crisis in patients with chronic hemolytic anemia, such as thalassemia, due to its specific effect on erythroid progenitor cells in the bone marrow.</span></span></p>",
    "correct_choice_id": 229854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57626,
    "choices": [
      {
        "id": 229873,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum copper</span></span></p>"
      },
      {
        "id": 229874,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary copper</span></span></p>"
      },
      {
        "id": 229875,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver copper levels</span></span></p>"
      },
      {
        "id": 229876,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ceruloplasmin</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient had a history of hepatic dysfunction, and the physical examination finding of the eye is shown below. Which of the following is the best way for confirmation of the diagnosis in this patient? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf4.jpg\" style=\"height:296px; width:300px\" /></span></span></p>",
    "unique_key": "Q2509717",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669683,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Liver copper levels</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows a <strong>Kayser-Fleischer ring,</strong> which is a brownish or gray-green ring at the corneal margin, characteristic of Wilson&#39;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Wilson&#39;s disease is a disorder of copper metabolism leading to the accumulation of copper in various body tissues, including the liver, brain, and eyes. The Kayser-Fleischer ring, combined with hepatic dysfunction, strongly suggests Wilson&rsquo;s disease. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most reliable method for confirming the diagnosis of Wilson&rsquo;s disease is measuring liver copper levels. Elevated hepatic copper content (greater than 250 &micro;g/g dry weight) is diagnostic of Wilson&rsquo;s disease, reflecting the abnormal accumulation of copper in liver tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum copper:</span></strong><span style=\"font-size:12.0pt\"> Serum copper levels are usually low in Wilson&rsquo;s disease because copper is not adequately bound to ceruloplasmin. However, this test is not specific or reliable enough to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Urinary copper:</span></strong><span style=\"font-size:12.0pt\"> Urinary copper excretion is typically elevated in Wilson&#39;s disease and can be used as a supportive test but is not the gold standard for confirmation. It is often used to monitor treatment response rather than for initial diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum ceruloplasmin:</span></strong><span style=\"font-size:12.0pt\"> Serum ceruloplasmin levels are often low in Wilson&#39;s disease, but this is not specific and can be influenced by other factors, making it unreliable as a sole diagnostic tool.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liver copper levels measured from a liver biopsy are the most definitive and confirmatory test for diagnosing Wilson&rsquo;s disease, especially when characteristic signs like Kayser-Fleischer rings are present.</span></span></span></p>",
    "correct_choice_id": 229875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10038,
    "choices": [
      {
        "id": 40118,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rosai-Dorfman disease</span></span></span></p>"
      },
      {
        "id": 40119,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kimura disease</span></span></span></p>"
      },
      {
        "id": 40120,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis</span></span></span></p>"
      },
      {
        "id": 40121,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Juvenile Xanthogranuloma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child brought to OPD with complaints of fever, erythematous rash, and bone pain. X-ray of the skull revealed multiple lytic lesions. Skin biopsy shows prominent nuclear grooves with eosinophils as in the image below. Immunohistochemistry is positive for S100, CD1a. What is the likely diagnosis?&nbsp;&nbsp;(INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture10.jpg\" style=\"height:264px; width:300px\" /></p>",
    "unique_key": "Q1150000",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669186,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Langerhans cell histiocytosis</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The above history along with the histopathological image showing Langerhans cells (image A), <strong>CD1a and positive S100 positive, is suggestive of Langerhans cell histiocytosis (LCH).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134845.jpg\" style=\"height:493px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Rosai Dorfman disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rosai Dorfman disease doesn&rsquo;t show histiocytes. It presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Kimura disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kimura disease presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Juvenile Xanthogranuloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Juvenile Xanthogranuloma shows multinucleated giant cells. It presents with papular lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis (LCH)</span></strong><span style=\"font-size:12.0pt\"> is identified by a combination of clinical symptoms (such as bone pain, fever, and rash), characteristic histopathological features (nuclear grooves, eosinophils), and positive immunohistochemical markers (S100, CD1a). The presence of multiple lytic bone lesions, especially in the skull, is a key diagnostic clue.</span></span></span></p>",
    "correct_choice_id": 40120,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57628,
    "choices": [
      {
        "id": 229881,
        "text": "<p><span style=\"font-size:12.0pt;\">Endothelial injury</span></p>"
      },
      {
        "id": 229882,
        "text": "<p><span style=\"font-size:12.0pt;\">Neutrophil activation</span></p>"
      },
      {
        "id": 229883,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibrin deposition</span></p>"
      },
      {
        "id": 229884,
        "text": "<p><span style=\"font-size:12.0pt;\">Macrophage activation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has adult respiratory distress syndrome. Which of the following is the action of IL-8 in the pathogenesis in this patient? (NEET PG 2024)</span></p>",
    "unique_key": "Q2281467",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669675,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neutrophil activation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the pathogenesis of Adult Respiratory Distress Syndrome (ARDS), Interleukin-8 (IL-8) plays a crucial role as a potent chemokine that specifically attracts and activates neutrophils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neutrophil activation is a critical step in the inflammatory cascade that exacerbates endothelial injury and subsequent lung damage in ARDS. Neutrophils, once activated, release proteases, reactive oxygen species, and other inflammatory mediators that contribute to the damage of the alveolar-capillary membrane, further aggravating the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endothelial injury</strong>: While endothelial injury is an important early event in ARDS, it is not directly caused by IL-8. Instead, endothelial injury triggers the release of cytokines, including IL-8, which then leads to neutrophil recruitment and activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fibrin deposition</strong>: Fibrin deposition is a downstream event in ARDS and is a result of the damage caused by neutrophil activation and endothelial injury. IL-8 indirectly contributes to this through its role in neutrophil activation, but it is not directly responsible for fibrin deposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Macrophage activation</strong>: While macrophages are involved in the inflammatory response in ARDS, IL-8 primarily targets neutrophils, not macrophages. IL-8's main action is to attract and activate neutrophils rather than macrophages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IL-8 is a key mediator in ARDS that promotes neutrophil activation, which plays a major role in the amplification of inflammation and lung injury in the disease process.</span></p>",
    "correct_choice_id": 229882,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9788,
    "choices": [
      {
        "id": 39119,
        "text": "<p><span style=\"font-size:12.0pt;\">Alcohol</span></p>"
      },
      {
        "id": 39120,
        "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
      },
      {
        "id": 39121,
        "text": "<p><span style=\"font-size:12.0pt;\">CCI4</span></p>"
      },
      {
        "id": 39122,
        "text": "<p><span style=\"font-size:12.0pt;\">Pesticides</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of liver<strong> </strong>failure?</span> (AIIMS MAY 2019)</p>",
    "unique_key": "Q2086524",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669544,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Paracetamol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>most common cause of liver failure is paracetamol poisoning.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen is the leading cause of drug-induced acute liver failure. The most common prescription drugs causing idiosyncratic injury (that is, drug toxicity unrelated to drug dosage) include antibiotics and, in particular, isoniazid, nonsteroidal analgesics, and anti-seizure.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Paracetamol poisoning is a medical emergency that requires prompt management to prevent serious liver damage and other complications. The general steps involved in the management of acute paracetamol poisoning:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. <strong>Decontamination</strong>: If the ingestion of paracetamol occurred <strong>within the last 1-2 hours</strong>, <strong>activated charcoal </strong>can be given orally to reduce the absorption of paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. <strong>Treatment with antidote</strong>: <strong>N-acetylcysteine (NAC. is the specific antidote </strong>for paracetamol poisoning. It is <strong>most effective if given within 8 hours of ingestion</strong> of the overdose. NAC replenishes the depleted glutathione stores in the liver, which helps to prevent liver damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. <strong>Monitoring and supportive care</strong>: Patients with paracetamol poisoning require close monitoring, particularly for liver and kidney function, electrolytes, blood glucose, and acid-base balance. Treatment with intravenous fluids, glucose and electrolytes may be necessary to maintain fluid and electrolyte balance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>RUMACK MATTHEW NOMOGRAM</strong> is used for monitoring:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-363.jpg\" alt=\"\" width=\"500\" height=\"330\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4.&nbsp;<strong>Referral for specialist care</strong>: In severe cases of paracetamol poisoning, the patient may require specialist care in a hospital setting, including referral to a <strong>liver transplant center.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Alcohol</strong>: Chronic alcohol consumption is a significant cause of liver disease, including cirrhosis, but paracetamol is the leading cause of acute liver failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. CCl4 (Carbon Tetrachloride)</strong>: CCl4 is a chemical that can cause liver damage, but it is not a common cause of liver failure compared to paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Pesticides</strong>: Certain pesticides can cause liver toxicity, but they are not as common a cause of liver failure as paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Paracetamol poisoning is the most common cause of acute liver failure, the mechanism involves free radical injury and so and it is a medical emergency that requires prompt treatment with N-acetylcysteine (NAC) and close monitoring to prevent serious complications, including liver failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotrans pathologic basis of disease, 11<sup>th</sup> edition, Pg 1635</strong></span></p>",
    "correct_choice_id": 39120,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10003,
    "choices": [
      {
        "id": 39978,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
      },
      {
        "id": 39979,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-c, 2-d, 3-a, 4-b</span></span></span></p>"
      },
      {
        "id": 39980,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-d, 2-a, 3-b, 4-c</span></span></span></p>"
      },
      {
        "id": 39981,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-b, 2-a, 3-c, 4-d</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following cells with their locations:&nbsp;(INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113620_lLxRHlh.jpg\" style=\"height:278px; width:600px\" /></p>",
    "unique_key": "Q2597165",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669685,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) 1-b, 2-a, 3-c, 4-d </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct matches for the cells and their respective locations are as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kupffer cells (b) Liver:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Kupffer cells are specialized macrophages located in the liver, involved in the breakdown of red blood cells and the immune response within the liver.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parietal cells (a) Stomach:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Parietal cells are found in the lining of the stomach and are responsible for secreting hydrochloric acid (HCl), which aids in digestion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dust cells (c) Alveoli:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Dust cells, also known as alveolar macrophages, are found in the alveoli of the lungs. They play a crucial role in removing inhaled particles and pathogens from the alveolar spaces.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clara cells (d) Bronchioles:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Clara cells, now more commonly referred to as club cells, are found in the bronchioles of the lungs. They secrete surfactant proteins and detoxify harmful substances inhaled into the lungs.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113757.jpg\" style=\"height:444px; width:1000px\" /></p>",
    "correct_choice_id": 39981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 10362,
    "choices": [
      {
        "id": 41414,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Relaxation of lower esophageal sphincter</span></span></span></p>"
      },
      {
        "id": 41415,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Defective peristalsis</span></span></span></p>"
      },
      {
        "id": 41416,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased release of NO and VIP in the distal part of esophagus</span></span></span></p>"
      },
      {
        "id": 41417,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased tone of the lower esophageal sphincter</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true about the pathology of achalasia cardia? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q1834051",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669480,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decreased release of NO and VIP in the distal part of esophagus&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Achalasia cardia is characterized by decreased release of NO and VIP in the distal part of esophagus.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The LES relaxes during swallowing due to the release of nitric oxide and vasoactive intestinal polypeptide from inhibitory neurons, as well as the interruption of normal cholinergic signaling. These inhibitory neurons degenerate in achalasia cardia, resulting in decreased NO and VIP release. This results in increased LES tone.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Relaxation of lower esophageal sphincter:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. In achalasia cardia, there is incomplete relaxation of the LES, not relaxation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Defective peristalsis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While this statement is related to achalasia cardia, it is not the most accurate or complete description of the pathology. The correct answer focuses specifically on the decreased release of NO and VIP, which directly explains the increased LES tone and subsequent symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Decreased tone of the lower esophageal sphincter:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. In achalasia cardia, the tone of the LES is increased, not decreased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The triad of achalasia cardia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>is as follows:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incomplete relaxation of LES</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased tone of LES</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent peristalsis (aperistalsis)</span></span></span></li>\r\n</ol>",
    "correct_choice_id": 41416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9966,
    "choices": [
      {
        "id": 39830,
        "text": "<p><span style=\"font-size:12.0pt;\">Esophagitis</span></p>"
      },
      {
        "id": 39831,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 39832,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
      },
      {
        "id": 39833,
        "text": "<p><span style=\"font-size:12.0pt;\">Barrett's esophagus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with heartburn and increased salivation. Upper gastrointestinal endoscopy was done, and the biopsy result is shown below. What is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/43.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p>",
    "unique_key": "Q3061073",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669705,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Barrett\u2019s esophagus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This image indicates the diagnostic features of Barrett's esophagus. Note the transition between esophageal squamous mucosa and Barrett metaplasia, with abundant metaplastic goblet cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-170620.png\" alt=\"\" width=\"300\" height=\"239\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a complication of chronic gastroesophageal reflux disease (GERD) characterized by intestinal metaplasia within the esophageal squamous mucosa. It is a premalignant condition that confers an increased risk of esophageal adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, patients diagnosed with Barrett's Esophagus require that periodic endoscopy with biopsy, for detection of dysplasia every 1-2 years to detect dysplasias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of dysplasia is associated with prolonged symptoms, longer segment length, increased patient age, and Caucasian</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/45.jpg\" alt=\"\" width=\"542\" height=\"475\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Esophagitis:</strong> While esophagitis, inflammation of the esophagus, may be seen in GERD, it does not show the characteristic intestinal metaplasia with goblet cells as seen in Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Squamous cell carcinoma:</strong> This type of cancer originates from the squamous cells of the esophagus and does not involve the metaplastic changes characteristic of Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Adenocarcinoma:</strong> Adenocarcinoma of the esophagus can develop from Barrett's esophagus, but the histological image provided is more consistent with the premalignant stage of Barrett's esophagus rather than adenocarcinoma itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a premalignant condition marked by intestinal metaplasia with goblet cells within the esophageal squamous mucosa, requiring regular surveillance for dysplasia and potential progression to adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1464</strong></span></p>",
    "correct_choice_id": 39833,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 10111,
    "choices": [
      {
        "id": 40410,
        "text": "<p><span style=\"font-size:12.0pt;\">1+</span></p>"
      },
      {
        "id": 40411,
        "text": "<p><span style=\"font-size:12.0pt;\">2+</span></p>"
      },
      {
        "id": 40412,
        "text": "<p><span style=\"font-size:12.0pt;\">3+</span></p>"
      },
      {
        "id": 40413,
        "text": "<p><span style=\"font-size:12.0pt;\">Gene Amplification is done irrespective of Her 2 Neu status</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In breast cancer, FISH for gene amplification will be done based on which of the following IHC staining for Her-2/neu?&nbsp;</span>(AIIMS MAY 2017)</p>",
    "unique_key": "Q2405330",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669678,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2+</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of breast cancer, the <strong>Her-2/neu</strong> status is typically assessed by <strong>Immunohistochemistry (IHC)</strong>. The Her-2/neu protein overexpression is graded on a scale of 0 to 3+ based on the intensity and completeness of membrane staining. This grading is crucial in guiding further testing and treatment decisions.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>IHC 0 or 1+</strong>: These scores indicate no or low levels of Her-2/neu expression, respectively. Tumors with these scores are considered Her-2 negative, and no further testing for gene amplification is typically needed.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 2+</strong>: This score is considered <strong>equivocal</strong>. When a tumor shows a 2+ result on IHC, it suggests an intermediate level of Her-2/neu expression. Because this result is not definitively positive or negative, <strong>Fluorescence in Situ Hybridization (FISH)</strong> testing is recommended to assess for <strong>gene amplification</strong> of Her-2/neu. FISH is a more sensitive and specific test that directly detects the amplification of the Her-2/neu gene, providing definitive information about the tumor's status.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 3+</strong>: A score of 3+ indicates a high level of Her-2/neu protein overexpression. Tumors with this score are considered <strong>Her-2 positive</strong> and typically do not require further FISH testing, as the overexpression is sufficient to warrant Herceptin (trastuzumab) therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Herceptin</strong> is a targeted therapy that specifically inhibits the Her-2/neu receptor, which is overexpressed in some breast cancers, leading to more aggressive tumor behavior. Therefore, determining the correct Her-2/neu status through IHC and, if necessary, confirming with FISH is crucial in selecting the appropriate treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1+:</strong> IHC 1+ is considered Her-2/neu negative, and FISH testing is generally not indicated in these cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3+:</strong> IHC 3+ is strongly positive for Her-2/neu, making FISH testing unnecessary since the high expression level is sufficient to guide treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gene Amplification is done irrespective of Her 2 Neu status:</strong> This option is incorrect because FISH testing for gene amplification is specifically indicated in cases with an equivocal IHC result (2+), not irrespective of Her-2/neu status.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FISH for Her-2/neu gene amplification is performed when the IHC result is 2+, as this score is considered equivocal, requiring further testing to determine the appropriate therapeutic approach.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-367.jpg\" alt=\"\" width=\"500\" height=\"791\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/42.jpg\" alt=\"\" width=\"406\" height=\"445\"></span></p>",
    "correct_choice_id": 40411,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 9809,
    "choices": [
      {
        "id": 39203,
        "text": "<p><span style=\"font-size:12.0pt;\">Webbing of hands and toes are associated with risk of visceral anomalies</span></p>"
      },
      {
        "id": 39204,
        "text": "<p><span style=\"font-size:12.0pt;\">Noonan syndrome is more associated with cardiac defects</span></p>"
      },
      {
        "id": 39205,
        "text": "<p><span style=\"font-size:12.0pt;\">Absence of neck webbing is associated with higher risk of coarctation of aorta</span></p>"
      },
      {
        "id": 39206,
        "text": "<p><span style=\"font-size:12.0pt;\">Webbing of neck is associated with higher risk of cardiac anomalies</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which amongst the following is true about Turner's syndrome? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q1834341",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669481,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Webbing of neck is associated with higher risk of cardiac anomalies</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In Turner's syndrome, webbing of the neck is associated with a higher risk of cardiac anomalies.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome results from complete or partial monosomy of the X chromosome and is characterized primarily by hypogonadism in phenotypic females. It is the most common sex chromosome abnormality in females.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/951.jpg\" alt=\"\" width=\"677\" height=\"453\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Webbing of hands and toes are associated with risk of visceral anomalies:</strong> Webbing of hands and toes is not specifically associated with Turner syndrome, nor is it a marker for visceral anomalies. Webbing or syndactyly is more commonly seen in other congenital conditions and does not relate directly to the risk of cardiac anomalies in Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Noonan syndrome is more associated with cardiac defects:</strong> While Noonan syndrome does indeed have a high association with cardiac defects, the question pertains specifically to Turner syndrome. Noonan syndrome and Turner syndrome have some overlapping features, but Noonan syndrome is a distinct genetic disorder that is not related to the X chromosome abnormalities seen in Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Absence of neck webbing is associated with higher risk of coarctation of aorta:</strong> This statement is incorrect. In Turner syndrome, the presence, not the absence, of neck webbing is associated with a higher risk of coarctation of the aorta and other cardiac anomalies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Turner syndrome, the presence of neck webbing is significantly associated with an increased risk of cardiac anomalies, particularly coarctation of the aorta and bicuspid aortic valve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8<sup>th</sup> edition, Pg no 318-319</strong></span></p>",
    "correct_choice_id": 39206,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 24725,
    "choices": [
      {
        "id": 98861,
        "text": "<p><span style=\"font-size:12.0pt;\">Platelets is stored between 20\u00b0c to 24\u00b0C with a shelf life of 5 days</span></p>"
      },
      {
        "id": 98862,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryoprecipitate is stored at -20\u00b0C with a shelf life of 6 months</span></p>"
      },
      {
        "id": 98863,
        "text": "<p><span style=\"font-size:12.0pt;\">Packed red cells stored with adenine, glucose, mannitol and saline is stored between -5\u00b0C to -15 \u00b0C with a shelf life of 5 weeks</span></p>"
      },
      {
        "id": 98864,
        "text": "<p><span style=\"font-size:12.0pt;\">Fresh frozen plasma is stored between -5\u00b0C to -15\u00b0 C with a shelf life of 2 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true about blood products?</span> <span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q2196156",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669550,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelets is stored between 20\u00b0 C to 24\u00b0 C with a shelf life of 5 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Platelets can be stored at temperatures ranging from 20\u00b0C to 24\u00b0C, and they have a shelf life of 5 days (with continuous agitation)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cryoprecipitate is stored at -20\u00b0C with a shelf life of 6 months</strong>: This statement is incorrect because cryoprecipitate is typically stored at temperatures between -18\u00b0C to -30\u00b0C with a shelf life of 1 year. Cryoprecipitate is rich in clotting factors like fibrinogen, Factor VIII, and von Willebrand factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Packed red cells stored with adenine, glucose, mannitol, and saline is stored between -5\u00b0C to -15\u00b0C with a shelf life of 5 weeks</strong>: This statement is incorrect. Packed red blood cells stored with solutions like SAGM (Saline, Adenine, Glucose, Mannitol) are typically stored at temperatures between 2\u00b0C to 6\u00b0C, not -5\u00b0C to -15\u00b0C, and they have a shelf life of up to 42 days, not 5 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fresh frozen plasma is stored between -5\u00b0C to -15\u00b0C with a shelf life of 2 years</strong>: This statement is incorrect. Fresh frozen plasma (FFP) is usually stored at temperatures between -18\u00b0C to -30\u00b0C and has a shelf life of 1 year.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anti-coagulants solution and shelf life</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-175332.png\" alt=\"\" width=\"1000\" height=\"455\"></p>",
    "correct_choice_id": 98861,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10447,
    "choices": [
      {
        "id": 41754,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thymoma</span></span></span></p>"
      },
      {
        "id": 41755,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-Hodgkin lymphoma</span></span></span></p>"
      },
      {
        "id": 41756,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bronchogenic Carcinoma</span></span></span></p>"
      },
      {
        "id": 41757,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Germ cell tumor</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old female patient is diagnosed with pure red cell aplasia and a mediastinal mass. Which of the following can be the likely cause? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q1787393",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669219,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Thymoma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thymoma is the most likely diagnosis for the clinical presentation of a mediastinal mass with pure red cell aplasia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pure red cell aplasia (PRCA) is a rare syndrome characterized by a selective failure of erythroid element production in the bone marrow but normal granulopoiesis and megakaryocytopoiesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patients have normocytic normochromic anemia, with normal granulocyte and platelet counts. Reticulocytes are significantly reduced or absent.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Non-Hodgkin lymphoma: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Association:</span></strong><span style=\"font-size:12.0pt\"> While lymphomas can present as mediastinal masses and may cause cytopenias, they are not specifically associated with pure red cell aplasia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bronchogenic Carcinoma: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Association:</span></strong><span style=\"font-size:12.0pt\"> Bronchogenic carcinoma typically presents with respiratory symptoms and does not have a known association with PRCA.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Germ cell tumor: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Association:</span></strong><span style=\"font-size:12.0pt\"> Germ cell tumors can present as mediastinal masses but are not specifically linked to PRCA.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thymoma is the most likely cause of a mediastinal mass in a patient with pure red cell aplasia. PRCA is characterized by a selective deficiency of erythroid precursors in the bone marrow, leading to severe anemia with normal granulocyte and platelet counts, and is often associated with thymoma.</span></span></span></p>",
    "correct_choice_id": 41754,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 24728,
    "choices": [
      {
        "id": 98873,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid light chain (AL)</span></span></span></p>"
      },
      {
        "id": 98874,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid associated protein (AA)</span></span></span></p>"
      },
      {
        "id": 98875,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid &beta;2 microglobulin (A&beta;2M)</span></span></span></p>"
      },
      {
        "id": 98876,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amyloid transthyretin (ATTR)</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which type of amyloidosis is more likely to develop in a patient undergoing long-term hemodialysis due to renal failure?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q1458022",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669211,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Amyloid&nbsp;&beta;2 microglobulin (A&beta;2M)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemodialysis-associated amyloidosis (HAA)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a condition that occurs in patients who have been undergoing long-term hemodialysis, typically for chronic renal failure. The culprit protein in this form of amyloidosis is <strong>&beta;2-microglobulin (A&beta;2M)</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&beta;2-microglobulin</span></strong><span style=\"font-size:12.0pt\"> is a component of MHC class I molecules and is normally filtered out by the kidneys. In patients with renal failure, and especially those on long-term dialysis, &beta;2-microglobulin accumulates because it is not efficiently removed by the dialysis membrane. Over time, this accumulation can lead to the deposition of amyloid fibrils composed of A&beta;2M in various tissues, particularly around joints, leading to conditions like carpal tunnel syndrome and other forms of osteoarticular amyloidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amyloid light chain (AL)</span></strong><span style=\"font-size:12.0pt\">: This type of amyloidosis is associated with plasma cell dyscrasias, such as multiple myeloma, where abnormal light chains are produced and deposit as amyloid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amyloid associated protein (AA)</span></strong><span style=\"font-size:12.0pt\">: AA amyloidosis is secondary to chronic inflammatory conditions like tuberculosis, rheumatoid arthritis, or chronic infections, where Serum Amyloid A (SAA) is overproduced and deposits as amyloid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Amyloid transthyretin (ATTR)</span></strong><span style=\"font-size:12.0pt\">: ATTR amyloidosis involves transthyretin, a protein produced in the liver, which can form amyloid deposits either due to genetic mutations (familial amyloid polyneuropathies) or in wild-type form, primarily affecting the heart.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Long-term hemodialysis patients with renal failure may experience the development of amyloidosis due to the accumulation of A&beta;2-microglobulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additional Information</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Generalized/Systemic Amyloidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171322.png\" style=\"height:325px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">B. Localised Amyloidosis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171541.png\" style=\"height:451px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Hereditary Amyloidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-171641.png\" style=\"height:237px; width:1000px\" /></p>",
    "correct_choice_id": 98875,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 57623,
    "choices": [
      {
        "id": 229861,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Squamous cell cancer lung</span></span></span></p>"
      },
      {
        "id": 229862,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenocarcinoma lung</span></span></span></p>"
      },
      {
        "id": 229863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell carcinoma lung</span></span></span></p>"
      },
      {
        "id": 229864,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Large cell carcinoma lung</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient had a pulmonary mass which shows IHC staining with TTF-1 as shown in the image. What is the likely diagnosis in this patient? (NEET PG 2024)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf2.jpg\" style=\"height:273px; width:400px\" /></span></span></p>",
    "unique_key": "Q1034235",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669182,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Adenocarcinoma lung</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thyroid Transcription Factor-1 (TTF-1) is a nuclear protein that is a specific marker for adenocarcinoma of the lung and small cell carcinoma of the lung. However, it is most commonly associated with adenocarcinoma. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TTF-1 positivity indicates that the tumor cells are likely of lung or thyroid origin, with adenocarcinoma being the most common type of lung cancer associated with this marker. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, other markers like Napsin A and surfactant protein A1 are also specific to adenocarcinoma of the lung.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Squamous cell cancer lung:</span></strong><span style=\"font-size:12.0pt\"> Squamous cell carcinoma typically shows markers like <strong>P63, P40, or keratin.</strong> It does not stain positive for TTF-1, differentiating it from adenocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small cell carcinoma lung:</span></strong><span style=\"font-size:12.0pt\"> While TTF-1 can be positive in small cell carcinoma, other specific markers such as <strong>chromogranin, synaptophysin, and INSM-1</strong> are more indicative. TTF-1&#39;s presence alone, along with the given context, makes adenocarcinoma the more likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Large cell carcinoma lung:</span></strong><span style=\"font-size:12.0pt\"> This is generally a diagnosis of exclusion and does not have specific immunohistochemical markers like TTF-1. Large cell carcinoma is generally a diagnosis of exclusion, as it lacks specific markers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TTF-1 is a key immunohistochemical marker that strongly suggests adenocarcinoma of the lung, particularly when observed in a pulmonary mass.</span></span></span></p>",
    "correct_choice_id": 229862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9801,
    "choices": [
      {
        "id": 39171,
        "text": "<p><span style=\"font-size:12.0pt;\">TdT</span></p>"
      },
      {
        "id": 39172,
        "text": "<p><span style=\"font-size:12.0pt;\">CD1a</span></p>"
      },
      {
        "id": 39173,
        "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
      },
      {
        "id": 39174,
        "text": "<p><span style=\"font-size:12.0pt;\">Cytokeratin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not usually involved in the immunohistochemistry of acute lymphoblastic leukemia? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q1379460",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669209,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Cytokeratin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytokeratin is not a marker of acute lymphoblastic leukemia (ALL). It is an epithelial cell marker for thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immunophenotype in ALL \u2013</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Terminal deoxynucleotidyl-transferase (TdT), a specialized DNA polymerase, is positive in more than 95% of cases.</span></li><li><span style=\"font-size:12.0pt;\">Lymphoblasts usually express the pan B-cell marker CD19 and the transcription factor PAX5, as well as CD10.</span></li><li><span style=\"font-size:12.0pt;\">More mature \u201clate pre-B\u201d ALLs express CD10, CD19, CD20, and cytoplasmic IgM heavy chain (\u03bc chain).</span></li><li><span style=\"font-size:12.0pt;\">T-ALLs are arrested at various stages of pre-T cell development. In most cases the cells are positive for CD1, CD2, CD5, and CD7.</span></li><li><span style=\"font-size:12.0pt;\">\u201cLate\u201d pre-T cell tumors are positive CD3, CD4, and CD8</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-184729.png\" alt=\"\" width=\"1000\" height=\"380\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. TdT</strong>: A highly specific marker for ALL, present in over 95% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. CD1a</strong>: Commonly expressed in T-ALL, particularly in early T-cell development stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. CD3</strong>: A marker for T-cell lineage, used in identifying T-ALL and distinguishing it from B-cell lineage ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cytokeratin&nbsp;</strong>is not a marker for <strong>acute lymphoblastic leukemia (ALL)</strong> and is instead an epithelial cell marker used in identifying epithelial tumors such as thymoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Pg 111</strong></span></p>",
    "correct_choice_id": 39174,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 10094,
    "choices": [
      {
        "id": 40342,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It takes 4 -5 years for gall stones to develop</span></span></span></p>"
      },
      {
        "id": 40343,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Splenectomy is not protective against developing gall stones</span></span></span></p>"
      },
      {
        "id": 40344,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At least 25 % cases have a family history of hereditary spherocytosis</span></span></span></p>"
      },
      {
        "id": 40345,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in MCH is pathognomonic of HS</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements are true about hereditary spherocytosis?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>",
    "unique_key": "Q1980941",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669485,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;C) At least 25 % cases have a family history of &nbsp;hereditary spherocytosis.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atleast 25% cases of HS show familial inheritance since it is inherited as AD pattern more commonly.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-162158.jpg\" style=\"height:572px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture19.jpg\" style=\"height:232px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:102px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:102px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It takes 4 -5 years for gall stones to develop</span></strong><span style=\"font-size:12.0pt\">: Gall stones typically develop in individuals with HS around 20&ndash;25 years of age, not within 4-5 years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Splenectomy is not protective against developing gall stones</span></strong><span style=\"font-size:12.0pt\">: Splenectomy is a treatment option for HS and is protective against the development of certain complications, including hemolysis-related gallstones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong> <strong><span style=\"font-size:12.0pt\">Increase in MCH is pathognomonic of HS</span></strong><span style=\"font-size:12.0pt\">: High MCHC (mean corpuscular hemoglobin concentration) is a characteristic finding in HS, but it is not pathognomonic (exclusively diagnostic) of the disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">At least 25% of cases of hereditary spherocytosis have a family history, reflecting its autosomal dominant inheritance pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1195, 1196</span></strong></span></span></p>",
    "correct_choice_id": 40344,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10065,
    "choices": [
      {
        "id": 40226,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 40227,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      },
      {
        "id": 40228,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
      },
      {
        "id": 40229,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements is true regarding clear cell carcinoma of the kidney?</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET MAY 2022) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the most common sporadic renal tumor</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Associated with loss of long arm of chromosome 3</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arises from distal convoluted tubule</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cells show intracellular accumulation of glycogen and fat</span></span></span></li>\r\n</ol>",
    "unique_key": "Q1468201",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669212,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) 1, 4 </strong>&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CLEAR CELL CARCINOMA</span></u></strong><strong> </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(Most Common variant)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">VHL gene (Occasionally associated with von Hippel-Lindau syndrome). Associated with loss of short arm of chromosome 3.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arise most likely from proximal tubular epithelium, and usually occur as solitary unilateral lesions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiographic findings -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypervascular mass with homogeneous enhancement</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gross:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Solid mass with a golden-yellow appearance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology -&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clear cytoplasm due to washing of accumulated glycogen and lipid droplets. Prominent vasculature and sheets of polygonal cells.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statement 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Associated with loss of short arm of chromosome 3, not long.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statement 3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Arise most likely from proximal tubular epithelium, not distal.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/2.jpg\" style=\"height:308px; width:462px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clear cell carcinoma of the kidney is the most common sporadic renal tumor and is characterized by cells with intracellular accumulation of glycogen and fat, as well as an association with the loss of the short arm of chromosome 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1847-1849</span></strong></span></span></p>",
    "correct_choice_id": 40229,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10404,
    "choices": [
      {
        "id": 41582,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PML-RARA</span></span></span></p>"
      },
      {
        "id": 41583,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">BCR ABL</span></span></span></p>"
      },
      {
        "id": 41584,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMYC</span></span></span></p>"
      },
      {
        "id": 41585,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RUNX1 ETO</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All-trans retinoic acid is used in the treatment of tumor that is associated with which of the following genetic aberrations? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2180780",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669547,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) PML-RARA </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All-trans retinoic acid (ATRA) is used in the treatment of acute promyelocytic leukemia (APML), which is associated with the PML-RARA fusion gene.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The long arm of <strong>chromosome 17 encodes the retinoic acid alpha receptor gene (RARA</strong>). It is primarily expressed in hematopoietic cells and plays an important role in gene expression regulation. RARA is bound by the nuclear corepressor factor in the absence of retinoid acid, causing transcriptional repression. RARA is activated in the presence of retinoic acid, and promyelocytes undergo terminal differentiation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute promyelocytic leukemia (APL) is a distinct subtype of acute leukemia distinguished by abnormal promyelocyte proliferation, life-threatening coagulopathy, and the chromosome <strong>translocation t (15;17</strong>) (q22;q11-12). This results in an abnormal fusion protein known as PML-RARA, which has a low affinity for retinoids. This inhibits transcription and thus prevents gene expression for cellular differentiation. This leads to the accumulation of myeloid progenitor cells. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/48_GfWwlkg.jpg\" style=\"height:437px; width:300px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rx</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The condition is treated with all-trans retinoic acid <strong>(ATRA).</strong> It binds to the PML-RARA chimeric protein. This causes <strong>conformational change such that the protein regains its normal function</strong> and <strong>activates DNA transcription.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. BCR-ABL:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Associated with chronic myeloid leukemia (CML).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treated with tyrosine kinase inhibitors like imatinib, not ATRA.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. CMYC:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Associated with Burkitt lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Involves translocation t (8;14) affecting the c-Myc oncogene.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. RUNX1-ETO:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Associated with acute myeloid leukemia (AML) with t (8;21).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treated with standard chemotherapy regimens, not specifically ATRA.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All-trans retinoic acid (ATRA) is used in the treatment of acute promyelocytic leukemia (APL), which is characterized by the PML-RARA fusion gene resulting from the t(15;17) translocation. This treatment promotes the differentiation of leukemic promyelocytes, improving clinical outcomes in APL patients.</span></span></span></p>",
    "correct_choice_id": 41582,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 21430,
    "choices": [
      {
        "id": 85684,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      },
      {
        "id": 85685,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 7, 9, 10</span></span></span></p>"
      },
      {
        "id": 85686,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">8, 9, 11</span></span></span></p>"
      },
      {
        "id": 85687,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 7, 9, 10</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following are vitamin K dependent factors requiring gamma carboxylation? (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NEETPG 2023)</span></span></p>",
    "unique_key": "Q2144478",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669546,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 2, 7, 9, 10</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin K is essential for the post-translational modification of certain proteins required for blood coagulation. This modification is gamma carboxylation, which allows these proteins to bind calcium ions and participate effectively in the coagulation cascade.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vitamin K Dependent Factors:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Procoagulants:</span></strong><span style=\"font-size:12.0pt\"> Factors II (prothrombin), VII, IX, and X.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anticoagulants:</span></strong><span style=\"font-size:12.0pt\"> Protein C and Protein S.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These factors are synthesized in the liver and require gamma carboxylation of specific glutamic acid residues for their activity. Without this modification, they cannot bind calcium effectively, which is necessary for their role in coagulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin K dependent factors are procoagulants (factors 2,7,9,10) and anticoagulants (protein C and S). They require gamma carboxylation for their activity. </span></span></span></p>",
    "correct_choice_id": 85685,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 54495,
    "choices": [
      {
        "id": 217449,
        "text": "<p><span style=\"font-size:12.0pt;\">Chromogranin</span></p>"
      },
      {
        "id": 217450,
        "text": "<p><span style=\"font-size:12.0pt;\">NCAM</span></p>"
      },
      {
        "id": 217451,
        "text": "<p><span style=\"font-size:12.0pt;\">Synaptophysin</span></p>"
      },
      {
        "id": 217452,
        "text": "<p><span style=\"font-size:12.0pt;\">INSM</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an intranuclear immuno-histochemistry marker for neuroendocrine tumor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1072592",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669183,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) INSM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intranuclear immunohistochemistry markers are specifically located within the nucleus of the cell, unlike cytoplasmic or membranous markers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>INSM (Insulinoma Associated Protein 1)</strong> is a novel intranuclear marker used for the detection of neuroendocrine tumors. It is particularly useful in diagnosing various types of neuroendocrine tumors, including small cell carcinoma of the lung, medullary thyroid cancer, Merkel cell carcinoma, and paraganglioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chromogranin</strong>: Incorrect because it is a cytoplasmic marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NCAM</strong>: Incorrect because it is a membranous marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Synaptophysin</strong>: Incorrect because it is a cytoplasmic marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">INSM is an intranuclear marker for neuroendocrine tumors, distinguishing it from other cytoplasmic or membranous markers such as Chromogranin, NCAM, and Synaptophysin.</span></p>",
    "correct_choice_id": 217452,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10105,
    "choices": [
      {
        "id": 40386,
        "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
      },
      {
        "id": 40387,
        "text": "<p><span style=\"font-size:12.0pt;\">Schwannoma</span></p>"
      },
      {
        "id": 40388,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      },
      {
        "id": 40389,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old patient presents with bilateral proptosis. The biopsy from the region shows this pattern. What is the likely diagnosis?</span> (AIIMS MAY 2017)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/33.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p>",
    "unique_key": "Q2685159",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669691,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Schwannoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical history and biopsy picture is characteristic of schwannoma showing hypercellular areas (Antoni A), including Verocay bodies, as well as looser (hypocellular) areas, myxoid regions (Antoni B).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/34.jpg\" alt=\"\" width=\"400\" height=\"257\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/35.jpg\" alt=\"\" width=\"400\" height=\"200\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schwannomas are well-circumscribed, encapsulated masses that are attached to the nerve but can be separated from it. Tumors form firm, gray masses that may have areas of cystic and xanthomatous change.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">On microscopic examination tumors show a mixture of two growth patterns:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni A pattern of growth</strong>, elongated cells with cytoplasmic processes are arranged in fascicles in areas of moderate to high cellularity and scant stromal matrix; the <strong>\u201cnuclear-free zones\u201d of processes that lie between the regions of nuclear palisading are termed Verocay bodies.</strong></span></li><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni B pattern of growth</strong>, the tumor is less densely cellular (hypocellular) and consists of a loose meshwork of cells, <strong>microcysts</strong> and myxoid stroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Leiomyoma</strong>: Leiomyomas are benign smooth muscle tumors that do not typically present with the histological features observed in the provided image, such as Verocay bodies or the Antoni A/B patterns seen in schwannomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rhabdomyosarcoma</strong>: Rhabdomyosarcoma is a malignant tumor of skeletal muscle origin, often characterized by spindle-shaped cells and cross-striations on histology. It lacks the distinctive Antoni A and B patterns seen in schwannomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fibromatosis</strong>: Fibromatosis refers to a group of benign fibrous tissue proliferations that are locally aggressive but lack the encapsulated, well-circumscribed nature of schwannomas. The histology of fibromatosis does not show the Antoni A and B patterns or Verocay bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Schwannomas are benign nerve sheath tumors with distinct Antoni A and B growth patterns, including Verocay bodies. These features, along with the clinical presentation, are key to the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical presentations:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ufuhqjF.png\" width=\"1178\" height=\"951\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page no - 2595</strong></span></p>",
    "correct_choice_id": 40387,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9982,
    "choices": [
      {
        "id": 39894,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hodgkin lymphoma</span></span></span></p>"
      },
      {
        "id": 39895,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">EBV positive - DLBCL, NOS</span></span></span></p>"
      },
      {
        "id": 39896,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Infectious mononucleosis</span></span></span></p>"
      },
      {
        "id": 39897,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">EBV positive mucocutaneous ulcer</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old presented with fever. On examination, he had enlarged and ulcerated tonsils. His peripheral blood smear showed lymphocytosis. Monospot test was negative. Tonsillectomy was done and it showed large cells mixed with lymphocytes. The cells were positive for CD20, EB LMP1, MUM1, CD 79a. Background cells were positive for CD3. The cells are negative for CD15. Your most probable diagnosis is? (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NOV 2017)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/62.jpg\" style=\"height:241px; width:300px\" /></p>",
    "unique_key": "Q2413624",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669679,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) EBV positive &ndash; DLBCL, NOS </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario suggests a likely diagnosis of EB positive DLBCL, NOS (Epstein Barr virus-positive Diffuse Large B Cell Lymphoma, not otherwise specified.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given slide shows sheets of large lymphoid cells with irregular vesicular nuclei and prominent nucleoli typical of DLBCL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Approach to the question:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Negative monospot test rules out the diagnosis of infectious mononucleosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absence of Reed-Sternberg cell or its variants rules out Hodgkins lymphoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EBV-positive mucocutaneous ulcer is seen in immunocompromised individuals presenting as self-limiting ulcer which subsides on treatment. Biopsy will show atypical large B cells with RS cell-like morphology. Hence, this is cannot be the diagnosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EBV positive DLBCL (Diffuse Large B Cell Lymphoma) </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diffuse large B-cell lymphoma&nbsp;<strong>(DLBCL) is the most common form of NHL.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Age &gt; 50yrs </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No past history of lymphoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presents as a rapidly enlarging mass at nodal or extra-nodal site.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunodeficiency-associated large B-cell lymphoma occurs in the setting of severe T-cell</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">immunodeficiency (e.g., advanced HIV infection and allogeneic bone marrow transplantation). The neoplastic B cells are usually infected with EBV, which plays a critical pathogenic role. Restoration of T-cell immunity may lead to regression of these proliferations</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Immunohistochemistry is positive for CD 20, CD 79a, IRF4/MUM1. <strong>EBV LMP-1&nbsp;</strong>(Latent membrane protein-1) is positive in about 2/3<sup>rd</sup> of cases, while <strong>EBNA-2&nbsp;</strong>(Epstein-Barr nuclear antigen) is positive in the remaining 1/3rd of cases. It is <strong>negative for CD10 and BCL6.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Hodgkin lymphoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This diagnosis is less likely because Hodgkin lymphoma typically presents with Reed-Sternberg cells, which are positive for CD15 and CD30, not the immunophenotype seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Infectious mononucleosis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition is ruled out by the negative Monospot test and the presence of large atypical cells positive for B cell markers, which are more indicative of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. EBV positive mucocutaneous ulcer:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This condition usually occurs in immunocompromised individuals and presents as a self-limiting ulcer. The biopsy may show atypical large B cells with RS cell-like morphology, but the clinical scenario and histopathological findings are more consistent with EBV positive DLBCL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most probable diagnosis for a patient with enlarged, ulcerated tonsils, lymphocytosis, a negative Monospot test, and immunohistochemical findings of CD20, EB LMP1, MUM1, and CD79a positivity is <strong>EBV positive Diffuse Large B-Cell Lymphoma, NOS</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbin and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1121-1123</span></strong></span></span></p>",
    "correct_choice_id": 39895,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 73646,
    "choices": [
      {
        "id": 293525,
        "text": "<p><span style=\"font-size:12.0pt;\">Protein S deficiency</span></p>"
      },
      {
        "id": 293526,
        "text": "<p><span style=\"font-size:12.0pt;\">Homocystinuria</span></p>"
      },
      {
        "id": 293527,
        "text": "<p><span style=\"font-size:12.0pt;\">PNH (Paroxysmal Nocturnal Haemoglobinuria)</span></p>"
      },
      {
        "id": 293528,
        "text": "<p><span style=\"font-size:12.0pt;\">Antithrombin III deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not an inherited cause of thrombosis?&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q2055515",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669543,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) PNH (Paroxysmal Nocturnal Haemoglobinuria)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PNH is an acquired disorder, not inherited. It occurs due to acquired mutations in myeloid stem cells affecting the <strong>PIGA gene.</strong> This leads to deficiency of <strong>CD55 and CD59 proteins</strong> that normally protect cells from complement-mediated destruction.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The condition is characterized by <strong>intravascular hemolysis</strong>, thrombosis (particularly in unusual sites like <strong>hepatic veins causing Budd-Chiari syndrome</strong>), and <strong>pancytopenia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Protein S deficiency:&nbsp;</strong>Incorrect because it is an inherited thrombophilic condition. Protein S acts as a cofactor for Protein C and helps prevent excessive clotting.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Homocystinuria:&nbsp;</strong>Incorrect because it is an inherited metabolic disorder that causes elevated homocysteine levels, leading to increased risk of thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. AT III deficiency:&nbsp;</strong>Incorrect because Antithrombin III deficiency is an inherited condition that increases risk of thrombosis by reducing the ability to inhibit activated clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>PNH</strong> is an acquired disorder caused by somatic mutations, while <strong>Protein S deficiency, Homocystinuria, and AT III deficiency&nbsp;</strong>are inherited causes of thrombosis.</span></p>",
    "correct_choice_id": 293527,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 9937,
    "choices": [
      {
        "id": 39714,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 39715,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma</span></span></span></p>"
      },
      {
        "id": 39716,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leukemia</span></span></span></p>"
      },
      {
        "id": 39717,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child was brought to OPD with proptosis of left eye. On investigation, it was found to be a Desmin positive tumour. What can be the likely diagnosis? (AIIMS MAY 2021)</span></span></p>",
    "unique_key": "Q1638733",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669215,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;<strong>B) Embryonal rhabdomyosarcoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Given clinical scenario and tumor showing Desmin positive, points to a diagnosis of Embryonal Rhabdomyosarcoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">presents as a soft gray infiltrative mass. The tumor cells mimic skeletal muscle at various stages of differentiation and consist of sheets of both primitive round and spindled cells. Rhabdomyoblasts with straplike cytoplasm and visible cross-striations may be present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcoma botryoides&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is a variant of embryonal rhabdomyosarcoma that develops in the walls of hollow viscera such as the urinary bladder and vagina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture23.jpg\" style=\"height:127px; width:600px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Ewing&#39;s sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing&#39;s sarcoma is typically positive for CD99 and is more commonly found in bone or soft tissue, not usually associated with Desmin positivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Leukemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leukemia cells are positive for CD45 (leukocyte common antigen) and are not associated with Desmin positivity or presenting as a soft tissue mass with proptosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a malignant tumor of the retina, typically presenting with leukocoria (white pupillary reflex) and is associated with RB1 gene mutations. It is not associated with Desmin positivity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Embryonal rhabdomyosarcoma, a common pediatric soft tissue sarcoma, is typically Desmin-positive and can present with proptosis, particularly when it arises in the orbit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran pathologic basis of disease 8<sup>th</sup> edition pg 2435-2437</span></strong></span></span></p>",
    "correct_choice_id": 39715,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 57633,
    "choices": [
      {
        "id": 229901,
        "text": "<p><span style=\"font-size:12.0pt;\">Wiskott Aldrich syndrome</span></p>"
      },
      {
        "id": 229902,
        "text": "<p><span style=\"font-size:12.0pt;\">Wilson\u2019s disease</span></p>"
      },
      {
        "id": 229903,
        "text": "<p><span style=\"font-size:12.0pt;\">Achondroplasia</span></p>"
      },
      {
        "id": 229904,
        "text": "<p><span style=\"font-size:12.0pt;\">Leber disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the likely disease looking at the pattern of inheritance as provided in the image? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/pathology-neet-pg-aug-2024-pdf12.jpg\" alt=\"\" width=\"400\" height=\"287\"></span></p>",
    "unique_key": "Q2192706",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669548,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Wiskott Aldrich syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pedigree in the image shows an inheritance pattern typical of X-linked recessive conditions. In this pattern, affected males inherit the disease from carrier mothers, while females are usually carriers and do not show the disease. All affected individuals are male, and carrier females are represented by circles with a dot. Wiskott Aldrich syndrome follows an X-linked recessive inheritance, making it the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Wilson\u2019s disease:</strong> This condition is inherited in an <strong>autosomal recessive</strong> manner, meaning both males and females are equally affected, and carriers are not seen in the pattern observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Achondroplasia:</strong> This condition is inherited in an <strong>autosomal dominant</strong> manner. It would appear in every generation and affect both males and females equally, which is not the case in the presented pedigree.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leber disease:</strong> Leber hereditary optic neuropathy is inherited through <strong>maternal (mitochondrial) inheritance.</strong> It does not follow an X-linked recessive pattern and affects both sexes through maternal transmission only.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">X-linked recessive conditions are characterized by affected males and carrier females, as males have only one X chromosome, making them susceptible if the gene is defective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Major X-linked Recessive Disorders (Mnemonic: \"OBLIGATE\")</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9GPpeAY.png\" width=\"1453\" height=\"808\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other X-linked Recessive Diseases:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JXfDNOG.png\" width=\"1397\" height=\"564\"></span></p>",
    "correct_choice_id": 229901,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 73652,
    "choices": [
      {
        "id": 293549,
        "text": "<p><span style=\"font-size:16px;\">ALL&nbsp;B Lymphocyte&nbsp;Type</span></p>"
      },
      {
        "id": 293550,
        "text": "<p><span style=\"font-size:16px;\">ALL T Lymphocyte&nbsp;Type</span></p>"
      },
      {
        "id": 293551,
        "text": "<p><span style=\"font-size:16px;\">AML&nbsp;</span></p>"
      },
      {
        "id": 293552,
        "text": "<p><span style=\"font-size:16px;\">CML</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old child presents with gums bleeding, hepatosplenomegaly has a peripheral smear finding shown in the image. Flow cytometry was ordered for patient and CD19, CD22 and TdT came to be positive. What is the likely diagnosis?&nbsp;</span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET NOV 2024)&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xQObGOP.png\" width=\"752\" height=\"228\"></span></p>",
    "unique_key": "Q1515944",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669214,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) ALL B Lymphocyte Type</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is a case of B-cell Acute Lymphoblastic Leukemia (B-ALL) based on:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Clinical presentation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Young child (5 years old)</span></li><li><span style=\"font-size:16px;\">Gum bleeding (due to thrombocytopenia)</span></li><li><span style=\"font-size:16px;\">Hepatosplenomegaly</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Peripheral smear:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Shows lymphoblasts with:&nbsp;</span><ul><li><span style=\"font-size:16px;\">Scanty agranular cytoplasm</span></li><li><span style=\"font-size:16px;\">Condensed chromatin</span></li><li><span style=\"font-size:16px;\">No abnormal granules</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Flow cytometry findings:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Positive for:</span><ul><li><span style=\"font-size:16px;\">CD19 (B-cell marker)</span></li><li><span style=\"font-size:16px;\">CD22 (B-cell marker)</span></li><li><span style=\"font-size:16px;\">TdT (terminal deoxynucleotidyl transferase - immature lymphoid marker)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">These markers are characteristic of <strong>B-cell ALL</strong>. <strong>Flow cytometry</strong> is the investigation of choice for confirming the diagnosis and lineage assignment</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. ALL T Lymphocyte Type</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Incorrect because T-ALL would be positive for CD1, CD2, CD5, CD7 markers</span></li><li><span style=\"font-size:16px;\">Usually presents with mediastinal mass</span></li><li><span style=\"font-size:16px;\">Flow cytometry shows different markers than presented here</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. AML</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Incorrect because myeloblasts would show Auer rods and granular cytoplasm</span></li><li><span style=\"font-size:16px;\">Would be positive for MPO/NSE markers</span></li><li><span style=\"font-size:16px;\">Different flow cytometry pattern</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. CML</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Incorrect because CML shows mature granulocytes with left shift</span></li><li><span style=\"font-size:16px;\">Presents typically in adults</span></li><li><span style=\"font-size:16px;\">Positive for Philadelphia chromosome</span></li><li><span style=\"font-size:16px;\">Different flow cytometry pattern</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">B-cell ALL is characterized by lymphoblasts on <strong>peripheral smear and positivity for B-cell markers (CD19, CD22) and TdT on flow cytometry.</strong></span></p>",
    "correct_choice_id": 293549,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9804,
    "choices": [
      {
        "id": 39183,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Natural killer (NK) cells only</span></span></span></p>"
      },
      {
        "id": 39184,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Macrophages only</span></span></span></p>"
      },
      {
        "id": 39185,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NK cells, neutrophils and eosinophils</span></span></span></p>"
      },
      {
        "id": 39186,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neutrophils and eosinophils only</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibody-dependent cellular cytotoxicity (ADCC) is seen with:</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q2614850",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669689,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) NK cells, neutrophils and eosinophils</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibody-dependent cellular cytotoxicity (ADCC) is mediated by NK cells, neutrophils and eosinophils (killing certain parasitic worms like helminths via lgE antibodies).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In ADCC, cells/ antigens are coated with IgG antibodies. These are killed by effector cells like NK cells and macrophages. These effector cells bind to the target by their receptors for the Fc fragment of IgG and <strong>cell lysis proceeds without phagocytosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/947.jpg\" style=\"height:220px; width:700px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of NK Cells:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NK cells are key mediators of ADCC. They express the Fc receptor CD16 (Fc&gamma;RIII), which specifically recognizes the Fc portion of IgG antibodies bound to target cells. Upon engagement, NK cells degranulate, releasing cytotoxic molecules that induce apoptosis in the target cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Role of Neutrophils and Eosinophils:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Eosinophils are particularly involved in the ADCC response against larger parasites, such as helminths, where they utilize IgE antibodies to recognize and attack these pathogens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibody-dependent cellular cytotoxicity (ADCC) is primarily mediated by NK cells, neutrophils, and eosinophils, which kill target cells coated with antibodies through mechanisms that do not involve phagocytosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Pg no. 356</span></strong></span></span></p>",
    "correct_choice_id": 39185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 24746,
    "choices": [
      {
        "id": 98945,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal dominant</span></span></span></p>"
      },
      {
        "id": 98946,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Autosomal recessive</span></span></span></p>"
      },
      {
        "id": 98947,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudodominant inheritance</span></span></span></p>"
      },
      {
        "id": 98948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incomplete penetrance</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mode of inheritance from the pedigree chart given below:</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256107.jpg\" style=\"height:273px; width:400px\" /></span></span></p>",
    "unique_key": "Q2851521",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669696,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Autosomal dominant </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The pedigree chart given is suggestive of an autosomal dominant Disorders</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/whatsapp-image-2023-07-04-at-1256108.jpg\" style=\"height:197px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autosomal dominant inheritance is characterized by a consistent appearance of affected individuals in every generation, with no sex bias and manifestation in individuals who carry one copy of the mutant allele.</span></span></span></p>",
    "correct_choice_id": 98945,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9952,
    "choices": [
      {
        "id": 39774,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only 1 is correct.</span></span></span></p>"
      },
      {
        "id": 39775,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 &amp; 2 are correct.</span></span></span></p>"
      },
      {
        "id": 39776,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 &amp; 3 are correct.</span></span></span></p>"
      },
      {
        "id": 39777,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2 &amp; 4 are correct.</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements accurately describe the effects of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency?</span> <span style=\"font-size:12.0pt\">(AIIMS MAY 2021) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in reduced glutathione</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased NADPH</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased lipid peroxidation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased RBC membrane damage</span></span></span></li>\r\n</ol>",
    "unique_key": "Q2044825",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669542,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.&nbsp;<strong>B) 1 &amp; 2 are correct.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-192431.jpg\" style=\"height:968px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture28.jpg\" style=\"height:232px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Decrease in reduced glutathione:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This statement is correct. G6PD deficiency leads to reduced levels of NADPH, which is necessary to maintain GSH in its reduced form. Without sufficient GSH, RBCs are more susceptible to oxidative damage, which can lead to hemolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Decreased NADPH:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This statement is also correct. G6PD deficiency directly results in decreased production of NADPH in the pentose phosphate pathway. NADPH is necessary for the regeneration of reduced glutathione, which protects cells from oxidative stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Decreased lipid peroxidation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This statement is incorrect. In fact, G6PD deficiency leads to increased oxidative stress, which can result in increased lipid peroxidation, not a decrease. Lipid peroxidation damages cell membranes, contributing to RBC hemolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Decreased RBC membrane damage:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This statement is incorrect. The decreased levels of reduced glutathione and increased oxidative stress lead to more, not less, RBC membrane damage. This damage makes the RBCs more prone to hemolysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G6PD deficiency leads to decreased levels of NADPH and reduced glutathione, which are essential for protecting RBCs from oxidative damage. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1197</span></strong></span></span></p>",
    "correct_choice_id": 39775,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10092,
    "choices": [
      {
        "id": 40334,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-d, 2- c, 3- b, 4-a</span></span></span></p>"
      },
      {
        "id": 40335,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2- a, 3- d, 4- b</span></span></span></p>"
      },
      {
        "id": 40336,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-a, 2-b, 3- d, 4-c</span></span></span></p>"
      },
      {
        "id": 40337,
        "text": "<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-b, 2-a, 3-c, 4-d</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following stains with their respective tissue:</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-160905.jpg\" style=\"height:298px; width:700px\" /></p>",
    "unique_key": "Q2233717",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669554,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) 1-a, 2-b, 3-d, 4-c</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct match is 1- a, 2- b, 3- d, 4-c.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prussian blue (a)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to detect <strong>iron</strong> in tissue samples, specifically hemosiderin, a storage form of iron.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PAS (b)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The <strong>Periodic Acid-Schiff (PAS)</strong> stain is used to highlight <strong>glycogen</strong> and other carbohydrates in tissues. It is commonly used in diagnosing certain storage diseases and fungal infections.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congo red (c)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Congo red is a special stain used to detect <strong>amyloid</strong>, a protein that can abnormally accumulate in tissues, leading to conditions such as amyloidosis. Under polarized light, amyloid stained with Congo red shows apple-green birefringence.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fite Faraco stain (d)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to detect <strong>leprosy</strong> bacilli (Mycobacterium leprae) in tissue samples. It is a modification of the acid-fast stain and is specifically tailored to highlight these bacteria.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161158.jpg\" style=\"height:1112px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161508.jpg\" style=\"height:887px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-161538.jpg\" style=\"height:804px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 40336,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 9882,
    "choices": [
      {
        "id": 39494,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">EBV Negative</span></span></span></p>"
      },
      {
        "id": 39495,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD 30 Negative</span></span></span></p>"
      },
      {
        "id": 39496,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD 20 positive&nbsp;</span></span></span></p>"
      },
      {
        "id": 39497,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Poor prognosis compared to classical HL&nbsp;</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about nodular lymphocyte-predominant Hodgkin lymphoma? </span></span>(AIIMS NOV 2020)</p>",
    "unique_key": "Q2027583",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669489,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Poor prognosis compared to classical HL</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a subtype of Hodgkin lymphoma that is distinct from classical Hodgkin lymphoma (cHL). NLPHL is characterized by the presence of lymphocyte and histiocyte (L&amp;H) cells, also known as &quot;popcorn cells,&quot; which are CD20 positive and CD30 negative. Unlike classical Hodgkin lymphoma, NLPHL is typically EBV negative and has an excellent prognosis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. EBV Negative:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> NLPHL is usually negative for Epstein-Barr virus (EBV), distinguishing it from some subtypes of classical Hodgkin lymphoma, where EBV can be present.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. CD30 Negative:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CD30 is a marker typically expressed in classical Hodgkin lymphoma but not in NLPHL, making this statement true for NLPHL.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. CD20 Positive:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> NLPHL cells express CD20, a B-cell marker, which is another feature that distinguishes it from classical Hodgkin lymphoma, where CD20 is typically negative.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-181612.png\" style=\"height:642px; width:1000px\" /></p>",
    "correct_choice_id": 39497,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 54541,
    "choices": [
      {
        "id": 217633,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 2</span></span></span></p>"
      },
      {
        "id": 217634,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 and 3</span></span></span></p>"
      },
      {
        "id": 217635,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 and 4</span></span></span></p>"
      },
      {
        "id": 217636,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 3</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is a criteria for making a diagnosis of an anaphylactic reaction?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Swollen lips and urticaria</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breathing difficulty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Persistent abdominal pain and vomiting</span></span></span></li>\r\n</ol>",
    "unique_key": "Q2863467",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669698,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) 1 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactic reaction is a severe, life-threatening allergic reaction that is classified as a type I hypersensitivity reaction. This reaction involves the rapid release of histamine and other mediators from mast cells and basophils, leading to a variety of symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Criteria for Anaphylactic Reaction:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Swollen lips and urticaria</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are common manifestations of anaphylaxis due to histamine release causing increased vascular permeability and vasodilation, leading to swelling and hives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Breathing difficulty</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The release of leukotrienes and other mediators can cause bronchospasm, leading to respiratory distress and difficulty in breathing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Hypertension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactic reactions typically cause hypotension (low blood pressure) due to widespread vasodilation and increased capillary permeability, not hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Persistent abdominal pain and vomiting</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While abdominal pain and vomiting can occur in anaphylaxis, they are not the most typical or defining features. Persistent symptoms are less commonly associated with anaphylaxis compared to the more acute and severe symptoms like swelling and breathing difficulty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of swollen lips and urticaria along with breathing difficulty are key criteria for diagnosing an anaphylactic reaction, while hypertension and persistent abdominal pain are not typical features.</span></span></span></p>",
    "correct_choice_id": 217636,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 9964,
    "choices": [
      {
        "id": 39822,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell cycle will stop at G2</span></p>"
      },
      {
        "id": 39823,
        "text": "<p><span style=\"font-size:12.0pt;\">Cell cycle will stop at G1</span></p>"
      },
      {
        "id": 39824,
        "text": "<p><span style=\"font-size:12.0pt;\">There will be no effect on cell cycle as RB gene phosphorylation is not needed</span></p>"
      },
      {
        "id": 39825,
        "text": "<p><span style=\"font-size:12.0pt;\">The cell cycle progresses and cell divides</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">If the RB gene is hypophosphorylated, which of the following will happen? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q2040459",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669541,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cell cycle will stop at G1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the retinoblastoma (RB) gene is hypophosphorylated, then cell cycle will stop at G1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Rb protein is a tumor suppressor, which plays a pivotal role in the negative control of the cell cycle and in tumor progression. It has been shown that Rb protein (pRb) is responsible for a major G1 checkpoint, blocking S-phase entry and cell growth by binding to and inactivating a transcription factor (E2F). The phosphorylation of RB results in the release of E2F activating gene transcription and cell-cycle progression occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/42.jpg\" alt=\"\" width=\"562\" height=\"332\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Cell cycle will stop at G2:</strong> This is incorrect because the Rb protein specifically regulates the G1 to S phase transition, not the G2 phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. There will be no effect on cell cycle as RB gene phosphorylation is not needed:</strong> This is incorrect. The phosphorylation state of the Rb protein is crucial for its function in regulating the cell cycle. Hypophosphorylated Rb actively suppresses cell cycle progression at G1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. The cell cycle progresses and cell divides:</strong> This is incorrect because the hypophosphorylated form of Rb prevents the cell from progressing past the G1 phase, thereby halting cell division.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The hypophosphorylated state of the Rb protein prevents the cell cycle from progressing past the G1 phase by binding to and inactivating E2F, thereby acting as a crucial checkpoint in preventing uncontrolled cell proliferation.</span></p>",
    "correct_choice_id": 39823,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 73665,
    "choices": [
      {
        "id": 293601,
        "text": "<p><span style=\"font-size:16px;\">Associated with HLA DQ6/DQ11</span></p>"
      },
      {
        "id": 293602,
        "text": "<p><span style=\"font-size:16px;\">IgA Tissue Transglutaminase antibodies are present</span></p>"
      },
      {
        "id": 293603,
        "text": "<p><span style=\"font-size:16px;\">Marsh Criteria used for diagnosis</span></p>"
      },
      {
        "id": 293604,
        "text": "<p><span style=\"font-size:16px;\">IgG deamidated Gliadin antibodies are present</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A patient presents with abdominal pain, acute diarrhea, and is diagnosed with celiac disease. Which of the following statements is false regarding this condition? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1943694",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669484,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Associated with HLA DQ6/DQ11</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease is an autoimmune disorder triggered by the ingestion of gluten in genetically predisposed individuals. It is characterized by <strong>villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes.</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Associated with HLA DQ6/DQ11</strong> because celiac disease is associated with <strong>HLA DQ2 and DQ8,&nbsp;</strong>not HLA DQ6/DQ11.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IgA Tissue Transglutaminase antibodies are present:&nbsp;</strong>This statement is correct. The patients are going to be having the presence of IgA tissue transglutaminase antibodies \" These antibodies have high sensitivity and specificity for celiac disease diagnosis and are used as primary serological tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Marsh Criteria used for diagnosis:&nbsp;</strong>This statement is correct. \" Modified MARSH criteria is useful for making a diagnosis.\" The Marsh criteria classify the histopathological findings in small intestinal biopsies, ranging from normal mucosa to complete villous atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IgG deamidated Gliadin antibodies are present:&nbsp;</strong>This statement is correct. \" IgG deamidated gliadin antibodies are used in celiac disease diagnosis, especially in IgA-deficient patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Celiac disease is associated with HLA-DQ2 and HLA-DQ8, not HLA-DQ6/DQ11, and diagnosis involves IgA tissue transglutaminase antibodies, deamidated gliadin antibodies, and application of the Marsh criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important disease associated with HLA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PKQnfFG.png\" width=\"1289\" height=\"354\"></strong></span></p>",
    "correct_choice_id": 293601,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 9854,
    "choices": [
      {
        "id": 39382,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 1</span></span></span></p>"
      },
      {
        "id": 39383,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 8</span></span></span></p>"
      },
      {
        "id": 39384,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 9</span></span></span></p>"
      },
      {
        "id": 39385,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 4</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following caspase binds to Cytochrome C and APAF-1 complex? (AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q2212603",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669552,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) Caspase 9 </strong>&nbsp;</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Caspase 9 binds to Cyt-c and APAF-1 complex.</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Apoptotic stimuli cause the release <em>of <strong>c</strong></em><strong>ytochrome C into the cytosol</strong>. Cytochrome-C binds to a protein called <strong>APAF-1 (apoptosis-activating factor-1)</strong> to form the apoptosome.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">This complex then binds <strong>caspase-9,</strong> resulting in the activation of other caspases.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/984.jpg\" style=\"height:450px; width:630px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Caspase 1</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory response and not in the intrinsic apoptotic pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Caspase 8</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Associated with the extrinsic apoptotic pathway, activated by death receptors on the cell surface.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Caspase 4</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory response and not directly related to the intrinsic apoptotic pathway.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caspase 9 is the initiator caspase in the intrinsic apoptotic pathway and is activated by binding to the cytochrome C and APAF-1 complex (the apoptosome).</span></span></span></p>",
    "correct_choice_id": 39384,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10415,
    "choices": [
      {
        "id": 41626,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anthracotic pigment</span></span></span></p>"
      },
      {
        "id": 41627,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Melanin</span></span></span></p>"
      },
      {
        "id": 41628,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lipochrome</span></span></span></p>"
      },
      {
        "id": 41629,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemosiderin</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old patient presented with cough, fatigability, and weight loss. He was diagnosed with squamous cell carcinoma (SCC) on bronchoscopy. The resected specimen had a hilar lymph node that was 1cm in size and showed a black pigment. What is the black pigment likely to be? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q1192814",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669207,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Anthracotic pigment </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The black pigment in the resected bronchoscopic specimen&#39;s hilar lymph node is most likely an <strong>anthracotic pigment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The black colour is caused by <strong>carbon particle deposition</strong>. Carbon particles inhaled are engulfed by lung macrophages and transported to the hilar lymph nodes. This builds up and causes anthracosis, or blackening of the lung tissues.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture1_gmIujwz.jpg\" style=\"height:199px; width:277px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is commonly seen in people who work in environments with high levels of carbon particle pollution, such as coal mines. It is also the most common exogenous pigment found in humans as a result of urban air pollution. The aggregates of the carbon dust may induce fibroblastic reaction or emphysema that may lead to a condition called <strong>coal worker&#39;s pneumoconiosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Melanin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Melanin is a natural pigment found in the skin, hair, and eyes. It is not typically found in the lungs or lymph nodes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lipochrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lipochrome (also known as lipofuscin) is a yellow-brown pigment that accumulates with age in various tissues, but it does not present as black and is not typically found in the lungs or lymph nodes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hemosiderin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hemosiderin is an iron-storage complex and presents as a golden-brown pigment. It is associated with hemorrhage and iron metabolism but does not appear as black.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anthracotic pigment, resulting from the deposition of carbon particles, is the most likely cause of the black pigment observed in the hilar lymph node of a patient with squamous cell carcinoma. This is common in individuals exposed to high levels of environmental pollution or occupational hazards involving carbon particles.</span></span></span></p>",
    "correct_choice_id": 41626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9813,
    "choices": [
      {
        "id": 39219,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Hemangioblastoma</span></span></span></p>"
      },
      {
        "id": 39220,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 39221,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      },
      {
        "id": 39222,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neuroblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are small round blue cell tumors except: (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q2026209",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669488,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Hemangioblastoma</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is not a small round blue cell tumor.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Many childhood tumors have been collectively referred to as small round blue cell tumors due to their primitive histologic appearance. </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The differential diagnosis of such tumors includes neuroblastoma, Wilms tumor, lymphoma, rhabdomyosarcoma, Ewing sarcoma/primitive neuroectodermal tumor, medulloblastoma and retinoblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Ewing&#39;s sarcoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ewing&#39;s sarcoma is a classic example of a small round blue cell tumor. It is a highly malignant tumor that primarily affects bone and soft tissues, particularly in children and young adults.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Retinoblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Retinoblastoma is a small round blue cell tumor of the eye, commonly seen in children. It is characterized by the presence of small, undifferentiated cells with hyperchromatic nuclei.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Neuroblastoma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Neuroblastoma is another example of a small round blue cell tumor. It arises from neural crest cells and is most commonly found in the adrenal glands or along the sympathetic chain.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemangioblastoma is <strong>not</strong> classified as a small round blue cell tumor, unlike Ewing&#39;s sarcoma, retinoblastoma, and neuroblastoma.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and cotrans pathologic basis of disease 8<sup>th</sup> edition pg 882</span></strong></span></span></p>",
    "correct_choice_id": 39219,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10025,
    "choices": [
      {
        "id": 40066,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
      },
      {
        "id": 40067,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
      },
      {
        "id": 40068,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
      },
      {
        "id": 40069,
        "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify true statements about familial adenomatous polyposis? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Autosomal recessive inheritance</span></li><li><span style=\"font-size:12.0pt;\">If not treated, all cases progress to adenocarcinoma colon.</span></li><li><span style=\"font-size:12.0pt;\">KRAS mutations cause familial adenomatous polyposis</span></li><li><span style=\"font-size:12.0pt;\">It is associated with congenital hypertrophy of the retinal pigment epithelium.</span></li></ol>",
    "unique_key": "Q1116755",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669184,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Familial adenomatous polyposis (FAP) is a hereditary condition characterized by the development of numerous adenomatous polyps in the colon and rectum, often numbering in the hundreds to thousands. The condition is caused by mutations in the <strong>APC gene (chromosome 5q)</strong>, leading to autosomal dominant inheritance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>True Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: If not treated, all cases of FAP will progress to colorectal adenocarcinoma. This is because the polyps have a high potential to become malignant if not removed or if the patient does not undergo a prophylactic colectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4</strong>: FAP is associated with congenital hypertrophy of the retinal pigment epithelium, which is often used as a marker for the condition, especially in screening family members.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: FAP is inherited in an <strong>autosomal dominant</strong> pattern, not autosomal recessive. This means that a single copy of the mutated APC gene can cause the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3</strong>: FAP is primarily caused by mutations in the <strong>APC gene</strong>, not KRAS. While KRAS mutations are involved in colorectal cancer progression, they are not the cause of FAP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-123524.jpg\" alt=\"\" width=\"1000\" height=\"727\"></span></p>",
    "correct_choice_id": 40066,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 31889,
    "choices": [
      {
        "id": 127426,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti TPO antibody</span></p>"
      },
      {
        "id": 127427,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroglobulin antibody</span></p>"
      },
      {
        "id": 127428,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti Thyroid stimulating antibody</span></p>"
      },
      {
        "id": 127429,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti thyroid receptor antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A middle aged male presented with features of neck swelling, exophthalmos, sweating, tachycardia and tremors. Which of the following is the likely associated finding in this patient? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193206.jpg\" alt=\"\" width=\"250\" height=\"398\"></span></p>",
    "unique_key": "Q2728834",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669692,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Anti thyroid receptor antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient presents with classic signs of hyperthyroidism, including:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Neck swelling \u2192 Goiter</span></li><li><span style=\"font-size:12.0pt;\">Exophthalmos \u2192 Bulging eyes</span></li><li><span style=\"font-size:12.0pt;\">Sweating, tachycardia, tremors \u2192 Signs of increased sympathetic activity</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given history and the picture of the patient suggest a diagnosis of hyperthyroidism the commonest cause of which is <strong>Graves\u2019s disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common antibody subtype, known as thyroid-stimulating immunoglobulin (TSI), is observed in approximately 90% of patients. TSI binds to the TSH receptor and mimics its actions, stimulating adenyl cyclase and increasing the release of thyroid hormones.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti thyroid stimulating antibody cannot be the answer as such an antibody</span></li><li><span style=\"font-size:12.0pt;\">Since TSI stimulates the gland for the formation of thyroid hormones.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-193354.jpg\" alt=\"\" width=\"1000\" height=\"278\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anti-TPO antibody:</strong> Associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-thyroglobulin antibody:</strong> Also associated with Hashimoto's thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-thyroid stimulating antibody:</strong> Incorrect terminology for TSI, which is already covered under anti-thyroid receptor antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves' disease is associated with anti-thyroid receptor antibodies (TSI), which stimulate the thyroid gland to produce excess thyroid hormones, leading to hyperthyroidism. The presence of neck swelling, exophthalmos, and other hyperthyroid symptoms strongly suggests this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Graves Disease \u2013 Key Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KgbS7tT.png\" width=\"1030\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins 10<sup>th</sup>/ 1081</strong></span></p>",
    "correct_choice_id": 127429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9845,
    "choices": [
      {
        "id": 39346,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine specimen is used</span></span></span></p>"
      },
      {
        "id": 39347,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Sanger sequencing is used</span></span></span></p>"
      },
      {
        "id": 39348,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Study of fluid in tumor microenvironment</span></span></span></p>"
      },
      {
        "id": 39349,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">DNA is collected in micro vessels</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true regarding liquid-based cytology? (AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q2210963",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669551,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Urine specimen is used </strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology can also be done using a urine specimen. It is commonly used in cervical cancer screening in place of a pap smear.</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology is a method of preparing samples for examination in cytopathology. The sample is collected, normally by a small brush, in the same way as for a conventional smear test, but rather than the smear being transferred directly to a microscope slide, the sample is deposited into a small bottle of preservative liquid. At the laboratory, the liquid is treated to remove other elements such as mucus before a layer of cells is placed on a slide.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Liquid-based cytology uses:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Used in place of PAP smear for cervical screening (most common use)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Thyroid cyst fluid examination.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Oral lesions</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Body fluids sampling (e.g., urine, pleural effusions), brushing samples (e.g. gastrointestinal tract, lung), and fine needle aspiration.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Sanger sequencing is used</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Sanger sequencing is a method of DNA sequencing and is not related to liquid-based cytology.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Study of fluid in tumor microenvironment</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Liquid-based cytology is not specifically focused on the study of tumor microenvironment fluids; rather, it is a method for preparing and analyzing cellular samples.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. DNA is collected in micro vessels</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is not a description of liquid-based cytology but may relate to other molecular biology techniques.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liquid-based cytology can use urine specimens, among others, to prepare samples for cytological examination, offering advantages over traditional smear techniques in terms of sample preservation and clarity.</span></span></span></p>",
    "correct_choice_id": 39346,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "InvestigationBased"
    ]
  },
  {
    "id": 10001,
    "choices": [
      {
        "id": 39970,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
      },
      {
        "id": 39971,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      },
      {
        "id": 39972,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      },
      {
        "id": 39973,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements are true regarding sirtuins? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases. </span></span></span></li>\r\n</ol>",
    "unique_key": "Q1737419",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669218,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2, 3, 4</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sirtuins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are a family of proteins that have been widely studied for their role in regulating various cellular processes, including aging, metabolism, and stress responses. Here&#39;s a detailed breakdown of each statement:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins, particularly SIRT1, have been shown to enhance insulin sensitivity and promote glucose metabolism, which is crucial for maintaining energy homeostasis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins are known to regulate gene expression in ways that promote longevity. They are involved in the deacetylation of proteins that contribute to cell survival, repair, and metabolism, which are associated with extended lifespan in various organisms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There are seven known sirtuins in humans, designated SIRT1 through SIRT7, each with specific functions in different cellular compartments.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins function as NAD+-dependent deacetylases, a class of enzymes that remove acetyl groups from histone and non-histone proteins, influencing gene expression and protein activity.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sirtuins&nbsp;</span></strong><span style=\"font-size:12.0pt\">are a family of seven histone deacetylases involved in increasing insulin sensitivity, glucose metabolism, promoting genes associated with longevity, and playing a significant role in various cellular processes.</span></span></span></p>",
    "correct_choice_id": 39971,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10072,
    "choices": [
      {
        "id": 40254,
        "text": "<p><span style=\"font-size:12.0pt;\">Cervical carcinoma</span></p>"
      },
      {
        "id": 40255,
        "text": "<p><span style=\"font-size:12.0pt;\">Anal carcinoma</span></p>"
      },
      {
        "id": 40256,
        "text": "<p><span style=\"font-size:12.0pt;\">Oropharyngeal carcinoma</span></p>"
      },
      {
        "id": 40257,
        "text": "<p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following conditions are caused by high-risk strains of Human Papilloma virus except:</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p>",
    "unique_key": "Q2607942",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669687,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Laryngeal papillomatosis</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-120647.jpg\" alt=\"\" width=\"1000\" height=\"387\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis is not caused by high-risk HPV strains but by low-risk HPV strains (6 and 11).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cervical carcinoma:</strong> Caused by high-risk HPV strains, particularly HPV 16 and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anal carcinoma:</strong> Also associated with high-risk HPV strains, including HPV 16.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oropharyngeal carcinoma:</strong> Linked to high-risk HPV strains, notably HPV 16.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis is caused by low-risk HPV strains (6 and 11) and not by the high-risk strains associated with cancers such as cervical, anal, and oropharyngeal carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 563</strong></span></p>",
    "correct_choice_id": 40257,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 9942,
    "choices": [
      {
        "id": 39734,
        "text": "<p><span style=\"font-size:12.0pt;\">Gynecomastia and long limbs</span></p>"
      },
      {
        "id": 39735,
        "text": "<p><span style=\"font-size:12.0pt;\">Flat occiput</span></p>"
      },
      {
        "id": 39736,
        "text": "<p><span style=\"font-size:12.0pt;\">Webbing of neck and lymphedema</span></p>"
      },
      {
        "id": 39737,
        "text": "<p><span style=\"font-size:12.0pt;\">Short stature and polydactyly</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following feature is correct on the basis of given karyotype?</span> <span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/18.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
    "unique_key": "Q1933152",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669483,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Gynecomastia and long limbs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given karyotyping image shows '47, XXY' abnormality, which is seen in Klinefelter's syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-173214.png\" alt=\"\" width=\"583\" height=\"765\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Flat occiput</strong>: This feature is typically seen in <strong>Down syndrome</strong> (Trisomy 21).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Webbing of neck and lymphedema</strong>: These are characteristic features of <strong>Turner syndrome</strong> (45, X).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Short stature and polydactyly</strong>: These are features seen in <strong>Patau syndrome</strong> (Trisomy 13).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Klinefelter syndrome (47, XXY) is characterized by gynecomastia, long limbs, small testes, and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and cotran pathologic basis of disease 8<sup>th</sup> edition pg 316-317</strong></span></p>",
    "correct_choice_id": 39734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 57649,
    "choices": [
      {
        "id": 229965,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an inherited red blood cell disorder causing intravascular hemolysis</span></span></p>"
      },
      {
        "id": 229966,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis of the disorder is confirmed by sucrose lysis test</span></span></p>"
      },
      {
        "id": 229967,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the gold standard for diagnosing this condition</span></span></p>"
      },
      {
        "id": 229968,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonest cause of mortality is cardiac failure</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true/correct statement about paroxysmal nocturnal hemoglobinuria? (NEET PG 2024)</span></span></p>",
    "unique_key": "Q1900763",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669482,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Flow cytometry is the gold standard for diagnosing this condition</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, not inherited, clonal hematopoietic stem cell disorder that leads to red blood cell destruction (intravascular hemolysis), thrombosis, and bone marrow failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The gold standard for diagnosing PNH is flow cytometry, which detects the absence of GPI-anchored proteins (CD55 and CD59) on red blood cells, granulocytes, and monocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;The absence of these proteins makes cells vulnerable to complement-mediated destruction, characteristic of PNH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is an inherited red blood cell disorder causing intravascular hemolysis:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect because PNH is not inherited but acquired due to a somatic mutation in the PIGA gene in hematopoietic stem cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The diagnosis of the disorder is confirmed by sucrose lysis test:</span></strong><span style=\"font-size:12.0pt\"> The sucrose lysis test is an older screening test for PNH but is not confirmatory. It has largely been replaced by flow cytometry, which is more accurate and specific for detecting the absence of CD55 and CD59.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The commonest cause of mortality is cardiac failure:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect. The most common cause of mortality in PNH is thrombotic complications, especially hepatic vein thrombosis (Budd-Chiari syndrome), not cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the definitive test for diagnosing PNH by demonstrating the absence of CD55 and CD59 on blood cells.</span></span></p>",
    "correct_choice_id": 229967,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9971,
    "choices": [
      {
        "id": 39850,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute monocytic leukemia</span></p>"
      },
      {
        "id": 39851,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute myelomonocytic leukemia</span></p>"
      },
      {
        "id": 39852,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute lymphoblastic leukemia</span></p>"
      },
      {
        "id": 39853,
        "text": "<p><span style=\"font-size:12.0pt;\">Juvenile myelomonocytic leukemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy with fever, weight loss came to the hospital. On examination, he was pale and had significant lymphadenopathy. The bone marrow histology of the person is as given below. Your diagnosis is: (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/51.jpg\" alt=\"\" width=\"300\" height=\"240\"></span></p>",
    "unique_key": "Q1656582",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669216,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acute lymphoblastic leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given scenario with bone marrow histology showing lymphoblasts (condensed nuclear chromatin, small nucleoli, scanty agranular cytoplasm) is suggestive of acute lymphoblastic leukemia.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-161555.png\" alt=\"\" width=\"500\" height=\"215\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PBF Findings in acute lymphoblastic (ALL). The cell is large, with round to convoluted nuclei having high N/C ratio and no cytoplasmic granularity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALL is more common in childhood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features of ALL include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bone marrow failure - anemia, fever, infections, bleeding</span></li><li><span style=\"font-size:12.0pt;\">Mass effects due to neoplastic infiltration - bone pain, generalized lymphadenopathy, splenomegaly, hepatomegaly, and testicular enlargement</span></li><li><span style=\"font-size:12.0pt;\">CNS manifestations - headache, vomiting, and <strong>nerve palsies</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>B-ALL</strong> - Pancytopenia due to marrow involvement</span></li><li><span style=\"font-size:12.0pt;\"><strong>T-ALL</strong> - Mediastinal mass, compression of large vessels and airways in the mediastinum, lymphadenopathy, splenomegaly</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-171159.png\" alt=\"\" width=\"1000\" height=\"341\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Acute monocytic leukemia</strong> and <strong>Option&nbsp;B. Acute myelomonocytic leukemia</strong>: These leukemias typically present with different morphologic features, including monoblasts and myeloblasts, which show different cytological characteristics such as cytoplasmic granularity and different nuclear morphology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Juvenile myelomonocytic leukemia (JMML)</strong>: JMML is a rare childhood leukemia with a different clinical presentation, often including hepatosplenomegaly and elevated monocyte counts, and it does not present with the lymphoblast morphology seen in ALL.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute lymphoblastic leukemia (ALL) in children is characterized by the presence of lymphoblasts in the bone marrow and peripheral blood, along with clinical features of bone marrow failure and organ infiltration by malignant cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1113</strong></span></p>",
    "correct_choice_id": 39852,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 10427,
    "choices": [
      {
        "id": 41674,
        "text": "<p><span style=\"font-size:12.0pt;\">Turner syndrome</span></p>"
      },
      {
        "id": 41675,
        "text": "<p><span style=\"font-size:12.0pt;\">Down syndrome</span></p>"
      },
      {
        "id": 41676,
        "text": "<p><span style=\"font-size:12.0pt;\">Patau syndrome</span></p>"
      },
      {
        "id": 41677,
        "text": "<p><span style=\"font-size:12.0pt;\">Edward syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A girl presents with short stature, webbed neck, thick calves, shield -shaped chest, swelling of the ankle, and increased carrying angle. What is the likely diagnosis? (NEET PG 2021)</span></p>",
    "unique_key": "Q2880435",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669699,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Turner syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The constellation of symptoms including short stature, webbed neck, thick calves, shield-shaped chest, swelling of the ankles, and increased carrying angle is suggestive of Turner syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome is caused by complete or partial X-chromosome monosomy. In phenotypic females, it causes hypogonadism. In females, it is the most common sex chromosome abnormality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Important features associated with Turner's syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Short stature</span></li><li><span style=\"font-size:12.0pt;\">Webbing of neck</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Cubitus valgus</span></li><li><span style=\"font-size:12.0pt;\">Streak ovaries, infertility, amenorrhea</span></li><li><span style=\"font-size:12.0pt;\">Peripheral lymphedema at birth</span></li><li><span style=\"font-size:12.0pt;\">Low posterior hairline</span></li><li><span style=\"font-size:12.0pt;\">Broad chest and widely spaced nipples</span></li><li><span style=\"font-size:12.0pt;\">Pigmented nevi</span></li><li><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-11-30%20195617.jpg\" width=\"440\" height=\"671\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Down syndrome: </strong>(Trisomy 21) is characterized by intellectual disability, facial dysmorphism, and increased risk of certain medical conditions such as congenital heart defects and leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Patau syndrome:&nbsp;</strong>(Trisomy 13): characterised by severe intellectual disability, cleft lip/palate, polydactyly, microcephaly, congenital heart defects, and often leads to early infant mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Edward syndrome:&nbsp;</strong>(Trisomy 18) characterised by severe intellectual disability, micrognathia (small jaw), clenched fists with overlapping fingers, rocker-bottom feet, congenital heart defects, and also typically results in early infant mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Turner syndrome is characterized by features such as short stature, webbed neck, shield-shaped chest, peripheral lymphedema, and increased carrying angle, among other physical manifestations. It is caused by complete or partial monosomy of the X chromosome in phenotypic females.</span></p>",
    "correct_choice_id": 41674,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10496,
    "choices": [
      {
        "id": 41950,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
      },
      {
        "id": 41951,
        "text": "<p><span style=\"font-size:12.0pt;\">Aplastic anemia</span></p>"
      },
      {
        "id": 41952,
        "text": "<p><span style=\"font-size:12.0pt;\">Hairy cell leukemia</span></p>"
      },
      {
        "id": 41953,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymphoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following are associated with massive splenomegaly except: (AIIMS NOV 2021)</span></p>",
    "unique_key": "Q2132145",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669545,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Aplastic anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All the above are associated with massive splenomegaly except aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aplastic anemia</strong> is characterized by pancytopenia (a reduction in red blood cells, white blood cells, and platelets) due to the failure of the bone marrow. A key feature of aplastic anemia is the absence of splenomegaly. In fact, the presence of splenomegaly in a patient with pancytopenia often argues against the diagnosis of aplastic anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are several potential <strong>causes of splenomegaly:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Liver disease (cirrhosis, hepatitis): Parenchymal liver disease causes increased vascular pressure leading to an increase in spleen size.</span></li><li><span style=\"font-size:12.0pt;\">Hematologic malignancies (lymphomas, leukemias, myeloproliferative disorders): Neoplastic cells cause infiltration of the spleen leading to splenomegaly.</span></li><li><span style=\"font-size:12.0pt;\">Venous thrombosis (portal or hepatic vein thrombosis): This leads to an increase in vascular pressure leading to splenomegaly.</span></li><li><span style=\"font-size:12.0pt;\">Splenic congestion (venous thrombosis, portal hypertension, congestive heart failure).</span></li><li><span style=\"font-size:12.0pt;\">Cytopenias (Immune thrombocytopenic purpura, autoimmune hemolytic anemia, immune-mediated neutropenia, Felty syndrome): Immune-mediated destruction of red blood cells, white blood cells or platelets lead to functional splenomegaly</span></li><li><span style=\"font-size:12.0pt;\">Splenic sequestration (pediatric sickle cell disease, hemolytic anemias, thalassemias).</span></li><li><span style=\"font-size:12.0pt;\">Acute or chronic infection (bacterial endocarditis, infectious mononucleosis, HIV, malaria, tuberculosis, histiocytosis, abscess).</span></li><li><span style=\"font-size:12.0pt;\">Connective tissue diseases (systemic lupus erythematosus, rheumatoid arthritis, Adult-onset Still's disease, and some familial autoinflammatory syndromes).[4][5]</span></li><li><span style=\"font-size:12.0pt;\">Infiltrative disorders (sarcoidosis, amyloidosis, glycogen storage diseases).</span></li><li><span style=\"font-size:12.0pt;\">Splenic sequestration (pediatric sickle cell, hemolytic anemias, thalassemias).</span></li><li><span style=\"font-size:12.0pt;\">Focal lesions (hemangiomas, abscess, cysts, metastasis).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aplastic anemia is a syndrome of chronic primary hematopoietic failure. This results in pancytopenia (anemia, neutropenia, and thrombocytopenia). <strong>Splenomegaly is characteristically absent; if it is present, the diagnosis of aplastic anemia should be seriously questioned. Similarly, splenomegaly is also never seen in cases of ITP.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition pg. 1239, 1173</strong></span></p>",
    "correct_choice_id": 41951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10104,
    "choices": [
      {
        "id": 40382,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</span></p>"
      },
      {
        "id": 40383,
        "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</span></p>"
      },
      {
        "id": 40384,
        "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron responsive elements decreases transferrin receptor mRNA concentration and synthesis</span></p>"
      },
      {
        "id": 40385,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron responsive element decreases and ferritin synthesis increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding the internal iron homeostasis in iron-deficiency anemia? </span>(AIIMS MAY 2017)</p>",
    "unique_key": "Q1807567",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669479,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)</strong> <strong>Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In iron deficiency anemia, there is an increase in transferrin receptor mRNA concentration and synthesis.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155.png\" alt=\"\" width=\"1000\" height=\"277\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high. Low serum iron with increased iron-binding capacity results in a reduction of transferrin saturation to below 15%. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</strong>: This statement is incorrect. In iron deficiency, ferritin synthesis decreases as the body conserves iron, but the ferritin mRNA concentration does not increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Transferrin receptor 1 iron-responsive elements decreases transferrin receptor mRNA concentration and synthesis</strong>: This is incorrect because in iron deficiency, transferrin receptor 1 expression increases to maximize iron uptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ferritin mRNA concentration iron-responsive element decreases and ferritin synthesis increases</strong>: This is also incorrect. In iron deficiency, both ferritin mRNA levels and ferritin synthesis decrease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In iron-deficiency anemia, transferrin receptor 1 iron-responsive elements increase mRNA concentration and synthesis to enhance iron uptake, while ferritin levels decrease as the body attempts to conserve iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, pg 1231-1234</strong></span></p>",
    "correct_choice_id": 40383,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 10379,
    "choices": [
      {
        "id": 41482,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy</span></span></span></p>"
      },
      {
        "id": 41483,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease</span></span></span></p>"
      },
      {
        "id": 41484,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Whipple&#39;s disease</span></span></span></p>"
      },
      {
        "id": 41485,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pancreatitis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old patient presented to the clinic with a history of malabsorption, diarrhea, and poor appetite. Duodenal biopsy of the patient showed crypt hyperplasia, villi atrophy, and CD8+ cells in lamina propria. What is the most probable diagnosis? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2314349",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669676,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Celiac disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation and histopathological findings point to celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease is sometimes referred to as celiac sprue or gluten-sensitive enteropathy. In genetically predisposed individuals, it is an immune-mediated enteropathy triggered by the consumption of gluten-containing cereals such as <strong>Barley, Rye, Oat &amp; Wheat (BROW)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Almost all celiac disease patients have the class II <strong>HLADQ2 or HLA-DQ8 allele.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased numbers of <strong>intraepithelial CD8+ T lymphocytes</strong> (intraepithelial lymphocytosis), <strong>crypt hyperplasia</strong>, and <strong>villous atrophy</strong> characterize the histopathology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/16_jyjVm3Q.jpg\" style=\"height:315px; width:602px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prior to biopsy, noninvasive serologic tests are usually performed. The presence of IgA antibodies to <strong>tissue transglutaminase or IgA</strong> or IgG antibodies to deamidated gliadin is the most sensitive test. <strong>Anti-endomysial antibodies are more specific than other antibodies but less sensitive</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features: -</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malabsorption syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">with chronic refractory <strong>anemia,</strong> chronic diarrhea, bloating, abdominal pain, and marked weight loss. A characteristic itchy, blistering skin lesion, <strong>dermatitis herpetiformis</strong>, can be present in as many as 10% of patients, and the incidence of lymphocytic gastritis and <strong>lymphocytic colitis</strong> is also increased.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enteropathy associated T cell lymphoma</span></strong></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small intestinal adenocarcinoma</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment &ndash; <strong>Gluten free diet </strong>results in symptomatic improvement for most patients, but a gluten-free diet may also reduce the risk of long-term complications including anemia, female infertility, osteoporosis, and cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DAPSONE&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">for dermatitis herpetiformis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Environmental enteropathy:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy / tropical sprue is seen in tropical areas with poor sanitation. It is believed to be caused by one or more infectious agents <strong>that respond to antibiotics</strong>. Mucosa shows variable villous atrophy. Folic acid and B12 deficiency is common.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Whipple&#39;s disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Whipple&#39;s disease is a multisystemic disease caused by T. whipplei. Small intestinal biopsy shows PAS-positive macrophages (see image below).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/19_m0TNFkQ.jpg\" style=\"height:266px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic pancreatitis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Causes malabsorption due to exocrine pancreatic insufficiency. Not associated with the specific histopathological features seen in celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease is characterized by malabsorption, diarrhea, poor appetite, crypt hyperplasia, villous atrophy, and increased intraepithelial CD8+ T lymphocytes. It is diagnosed by serologic tests and confirmed with a duodenal biopsy. Treatment includes a strict gluten-free diet.</span></span></span></p>",
    "correct_choice_id": 41483,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9848,
    "choices": [
      {
        "id": 39358,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Transfusion reaction</span></span></span></p>"
      },
      {
        "id": 39359,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute adrenal crisis</span></span></span></p>"
      },
      {
        "id": 39360,
        "text": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Fat embolism</span></span></span></p>"
      },
      {
        "id": 39361,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hemorrhagic shock</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A 24-year-old man met with an road traffic accident and was brought to the casualty after 6 hours. His B.P. was 90/60 mm Hg, heart rate was 110/min, and Sp02 was 92%. A blood transfusion was done. After a few hours, the patient is febrile, tachypneic, and starts bleeding from the IV and NG tube sites. His SpO2 levels started falling. What could be the cause? (AIIMS MAY 2020)</span></span></span></p>",
    "unique_key": "Q3021124",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669704,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Transfusion reaction</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Given the clinical scenario the most likely diagnosis is acute hemolytic transfusion reaction causing DIC (disseminated intravascular coagulation) resulting in bleeding from IV catheter and nasogastric tube within a few hours of blood transfusion.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute Hemolytic Transfusion reaction</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Immune-mediated hemolysis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Preformed antibodies</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> in recipient lyse donor erythrocytes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Complement-mediated lysis occurs causing <strong>intravascular hemolysis and hemoglobinuria</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Severe cases, tissue factor released from the lysed erythrocytes may <strong>initiate DIC</strong>, which is a consumptive coagulopathy with bleeding manifestations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other complications include <strong>shock, acute kidney injury, and sometimes, death.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The various blood transfusion reactions according to their time of occurrence are as follows:</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Anaphylactic reaction</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> - Within a few seconds to minutes of the transfusion. Common in <strong>selective IgA deficiency patients.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Allergic/Urticarial reactions - Within 2-3 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Acute hemolytic transfusion reaction (AHTR) - Within 24 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Febrile <strong>non-hemolytic</strong> transfusion reaction (FNHT) - Within 6 hours of transfusion</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Delayed hemolytic transfusion reaction (DHTR) - After 24 hours of transfusion</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:10px\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong>TRALI vs TACO:</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-132115.png\" style=\"height:429px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">TRALI: transfusion-related acute lung injury, TACO: Transfusion-associated cardiac overload, CXR: chest X-ray, BNP: B type natriuretic peptide, PAOP: pulmonary artery occluding pressure.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Acute adrenal crisis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition involves sudden adrenal insufficiency, leading to hypotension, shock, and electrolyte imbalances. It would not typically cause the specific symptoms of hemolysis and DIC seen in this case.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fat embolism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Fat embolism syndrome can occur after long bone fractures, presenting with respiratory distress, neurological symptoms, and petechiae. However, it typically occurs within 24-72 hours after injury and is not directly associated with blood transfusions.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Hemorrhagic shock</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Hemorrhagic shock results from significant blood loss, leading to hypotension and tachycardia. While this could be a consideration, the transfusion reaction and subsequent DIC better explain the patient&#39;s clinical presentation.</span></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:10px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:10px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An acute hemolytic transfusion reaction (AHTR) can lead to disseminated intravascular coagulation (DIC), characterized by rapid onset of fever, bleeding from multiple sites, and hemolysis shortly after a blood transfusion.</span></span></span></p>",
    "correct_choice_id": 39358,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9916,
    "choices": [
      {
        "id": 39630,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
      },
      {
        "id": 39631,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
      },
      {
        "id": 39632,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
      },
      {
        "id": 39633,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
      }
    ],
    "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">A patient with cervical lymphadenopathy has (11;14) positive. Which of the following markers should be done to confirm the diagnosis? (</span></span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">NOV 2020)</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD10; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD 200; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">SOX11; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Cyclin D1</span></span></span></li>\r\n</ol>",
    "unique_key": "Q2608339",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669688,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 3, 4</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">t (11;14) creating CyclinD1-IgH fusion gene is seen in mantle cell lymphoma has its origin from naive B cell. </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Mantle cell lymphoma:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Uncommon lymphoid neoplasm that makes up about 8% of all NHL</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Usually presents in the fifth to sixth decades of life</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Male</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> predominance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Tumor cells closely resemble the normal mantle zone B cells that surround germinal centers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">More indolent, <strong>SOX11 variant</strong> that often presents with circulating disease with splenomegaly but without significant lymphadenopathy and with a low Ki67 (&lt;10%).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Features:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Painless lymphadenopathy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Splenomegaly</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Multifocal mucosal involvement of small bowel and colon - lymphomatoid polyposis</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Histology:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1116.jpg\" style=\"height:170px; width:574px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-180835.png\" style=\"height:290px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Immunophenotyping:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">High levels of <strong>cyclin D1</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD19, CD20</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Moderately high levels of surface Ig (usually IgM and IgD with &kappa; or &gamma; light chain)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CD5+ and CD23-,</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"> which helps to distinguish it from CLL/SLL. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The IgH genes lack somatic hypermutation, supporting an origin from a naive B cell.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CD10 (1):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CD10 is a marker commonly associated with follicular lymphoma and acute lymphoblastic leukemia, not mantle cell lymphoma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CD200 (2):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CD200 is expressed in chronic lymphocytic leukemia (CLL) and other B-cell lymphomas but is not a primary marker for mantle cell lymphoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with <strong>t(11;14)</strong> translocation, confirming the diagnosis of mantle cell lymphoma requires testing for <strong>Cyclin D1</strong> and <strong>SOX11</strong> expression.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Robbins pathologic basis of disease 8<sup>th</sup> edition pg 1132-1133</span></strong></span></span></p>",
    "correct_choice_id": 39633,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 9791,
    "choices": [
      {
        "id": 39131,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIBC increased, Ferritin decreased, Transferrin saturation increased</span></span></span></p>"
      },
      {
        "id": 39132,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIBC increased, Soluble transferrin receptor decreased, Ferritin increased</span></span></span></p>"
      },
      {
        "id": 39133,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIBC increased, Transferrin saturation decreased, Ferritin decreased</span></span></span></p>"
      },
      {
        "id": 39134,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TIBC increased, Transferrin saturation decreased, Ferritin increased</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following are features of iron deficiency anemia?</span> </span></span>(AIIMS MAY 2019)</p>",
    "unique_key": "Q1509060",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669213,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) TIBC increased, Transferrin saturation decreased, Ferritin decreased</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In iron deficiency anemia, TIBC is increased, transferrin saturation is decreased, and ferritin is decreased.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high. Low serum iron with increased iron-binding capacity results in a <strong>reduction of transferrin saturation to below 15%</strong>. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Differential Diagnosis: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-114103.png\" style=\"height:277px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Pg 1231-1234</span></strong></span></span></p>",
    "correct_choice_id": 39133,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 43909,
    "choices": [
      {
        "id": 175299,
        "text": "<p><span style=\"font-size:12.0pt;\">1 Only</span></p>"
      },
      {
        "id": 175300,
        "text": "<p><span style=\"font-size:12.0pt;\">1 &amp; 2 Only</span></p>"
      },
      {
        "id": 175301,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and&nbsp;3</span></p>"
      },
      {
        "id": 175302,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are the classical markers of a seminoma: (INICET NOV 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">KIT&nbsp;&nbsp;&nbsp;&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">OCT 3</span></li><li><span style=\"font-size:12.0pt;\">PLAP</span></li><li><span style=\"font-size:12.0pt;\">HCG</span></li></ol>",
    "unique_key": "Q2731615",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669693,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) 1, 2 and&nbsp;3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The classical markers of a seminoma include KIT (CD117), OCT 3 (also known as OCT3/4), and PLAP (Placental Alkaline Phosphatase). These markers are commonly used in the diagnosis and characterization of seminomas due to their high specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. KIT (CD117):&nbsp;</strong>A receptor tyrosine kinase that is strongly expressed in seminomas, aiding in differentiation from other testicular neoplasms.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. OCT 3 (OCT3/4):&nbsp;</strong>A transcription factor essential for maintaining the pluripotency of germ cells and expressed in seminomas, reflecting their embryonal origin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. PLAP (Placental Alkaline Phosphatase):&nbsp;</strong>Frequently elevated in seminomas, this enzyme helps in confirming the germ cell origin of the tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. HCG (Human Chorionic Gonadotropin):&nbsp;</strong>Although some seminomas may express low levels of HCG, it is not considered a classical marker like the others, being more indicative of non-seminomatous germ cell tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">HCG&nbsp;may be <strong>present in ~15\u201320% of seminomas. However it is a classical marker for Choriocarcinoma (produced by syncytiotrophoblastic cells)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Therefore, <strong>some seminomas can elevate serum hCG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">However:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Not seen in <strong>all seminoma</strong></span></li><li><span style=\"font-size:16px;\"><strong>More characteristic of choriocarcinoma</strong> and <strong>mixed germ cell tumors</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">When diagnosing seminoma, clinicians should primarily focus on markers KIT, OCT3/4, and PLAP due to their high specificity and relevance to the germ cell lineage. HCG, although sometimes present, is not a classical marker for seminoma.</span></p>",
    "correct_choice_id": 175301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10109,
    "choices": [
      {
        "id": 40402,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
      },
      {
        "id": 40403,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 40404,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
      },
      {
        "id": 40405,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has a HbA2 of 3% and HbF of 97%. A peripheral blood smear is taken. Which of the following blood pictures will be seen in this patient? </span>(AIIMS MAY 2017)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/40.jpg\" alt=\"\" width=\"699\" height=\"228\"></p>",
    "unique_key": "Q2846170",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669695,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. </strong></span><span style=\"background-color:transparent;font-size:11pt;\"><strong>A) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the patient's HbA2 and HbF levels, this patient likely has beta thalassemia major, a condition where the body produces less than normal amounts of hemoglobin beta chains. This results in a decrease in HbA, and an increase in HbF and HbA2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beta thalassemia will have high HbA2 levels (&gt;3.5%) and slightly increased HbF</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The peripheral blood smear of a patient with beta thalassemia major will show hypochromic microcytic red blood cells (Image 1), which are smaller and paler than normal. Howell-jolly bodies (image 2) will also be seen. These cells may also be more variable in size and shape, and may have a target cell appearance (Image 3) due to increased membrane-to-cytoplasm ratio.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other possible findings on the blood smear may include anisocytosis (variation in cell size), poikilocytosis (variation in cell shape), and nucleated red blood cells (if the patient has severe anemia).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's important to note that the blood smear alone is not sufficient to diagnose beta thalassemia major, and additional laboratory tests and genetic testing may be necessary for confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Image 2 shows Howell\u2013Jolly bodies, which are small, round, dark purple inclusions within red blood cells (RBCs), representing residual nuclear DNA fragments. These inclusions are typically removed by a healthy spleen; their presence often indicates splenic dysfunction or absence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conditions Associated with Howell\u2013Jolly Bodies</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Howell\u2013Jolly bodies is commonly associated with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Post-splenectomy: Following surgical removal of the spleen</span></li><li><span style=\"font-size:12.0pt;\">Functional asplenia or hyposplenism: Conditions like sickle cell disease can lead to spleen dysfunction</span></li><li><span style=\"font-size:12.0pt;\">Megaloblastic anemia: Due to vitamin B12 or folate deficiency</span></li><li><span style=\"font-size:12.0pt;\">Severe hemolytic anemia: Where rapid RBC destruction overwhelms the spleen's filtering capacity</span></li><li><span style=\"font-size:12.0pt;\">Myelodysplastic syndromes: Bone marrow disorders affecting blood cell production</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In beta thalassemia major, the peripheral blood smear typically shows hypochromic microcytic red blood cells and target cells, which are best represented by Image 1 and Image 3.</span></p>",
    "correct_choice_id": 40402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 43947,
    "choices": [
      {
        "id": 175451,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interferon gamma</span></span></span></p>"
      },
      {
        "id": 175452,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complement 5a protein</span></span></span></p>"
      },
      {
        "id": 175453,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histamine</span></span></span></p>"
      },
      {
        "id": 175454,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fever, cough, weight loss, histology of the pathology is as shown below. What is the most likely cytokine involved? (INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151657.JPG\" style=\"height:256px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q2741770",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669694,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Interferon gamma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IFN-</span><span dir=\"ltr\" lang=\"EL\" style=\"font-size:12.0pt\">&gamma; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is crucial in the immune response against intracellular pathogens, including the activation of macrophages and the formation of granulomas, as seen in tuberculosis and other granulomatous diseases. It is produced primarily by T-helper cells (Th1) and is critical for orchestrating the cellular immune response that results in the granuloma formation evident in the provided histology.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Complement 5a protein</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory process, enhancing the immune response by attracting immune cells to sites of infection, but not directly involved in granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Histamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A mediator in allergic reactions, involved in vasodilation and increased vascular permeability, not typically associated with chronic inflammatory or granulomatous responses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Prostaglandin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are lipid compounds that mediate inflammation. Like histamine, they are more often associated with immediate inflammatory responses and pain, rather than chronic inflammation or granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interferon gamma is key in managing intracellular infections and is responsible for the activation of macrophages and other immune cells that culminate in granuloma formation, a central feature in controlling persistent pathogens such as those seen in tuberculosis.</span></span></span></p>",
    "correct_choice_id": 175451,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 10433,
    "choices": [
      {
        "id": 41698,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&beta;-2 microglobulin</span></span></span></p>"
      },
      {
        "id": 41699,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium levels</span></span></span></p>"
      },
      {
        "id": 41700,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum creatinine</span></span></span></p>"
      },
      {
        "id": 41701,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protein levels</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a poor prognostic marker of multiple myeloma? (NEET PG 2021)</span></span></p>",
    "unique_key": "Q2892617",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669700,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans. A)</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>&beta;-2 microglobulin</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&beta;-2 microglobulin is a poor prognostic marker of multiple myeloma.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple myeloma is a plasma cell neoplasm commonly associated with lytic bone lesions, hypercalcemia, renal failure, and acquired immune abnormalities.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CRAB criteria for MM </span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypercalcemia: serum calcium &gt;11mg/dl </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">renal Insufficiency: serum creatinine &gt;2 mg/dl or creatinine clearance &lt;40 ml/min </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anemia: Hgb &lt;10 g/dl </span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lytic bone lesions </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/10_J5SuwJl.jpg\" style=\"height:216px; width:324px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Poor prognostic factors for multiple myeloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum <strong>Beta 2-microglobulin - It is the single most powerful predictor</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deletion of 17&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pITP53 sequences and the <strong>translocations t (14;16) and t(14;20)</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">serum Immunoglobulins</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated lactate dehydrogenase</span></strong></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High C-reactive protein</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased plasma cell proliferative activity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">High degree of bone marrow replacement</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Presence of plasmablastic morphology</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elevated serum soluble receptor for IL6</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Calcium levels:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Elevated calcium levels are part of the CRAB criteria and indicate disease activity, but are not as strong a prognostic marker as &beta;-2 microglobulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum creatinine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Increased serum creatinine is also part of the CRAB criteria and indicates renal involvement, but it is not the single most powerful predictor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Protein levels:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Protein levels can be elevated due to monoclonal proteins produced by myeloma cells, but again, they are not as powerful a prognostic marker as &beta;-2 microglobulin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&beta;-2 microglobulin is the single most powerful predictor of poor prognosis in multiple myeloma, reflecting the tumor burden and the rate of disease progression.</span></span></span></p>",
    "correct_choice_id": 41698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10388,
    "choices": [
      {
        "id": 41518,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin B12 deficiency</span></span></span></p>"
      },
      {
        "id": 41519,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate deficiency</span></span></span></p>"
      },
      {
        "id": 41520,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pyridoxine deficiency</span></span></span></p>"
      },
      {
        "id": 41521,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niacin deficiency</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old male patient comes with complaints of abdominal pain, nausea, and vomiting. A peripheral blood smear reveals macrocytes and hypersegmented neutrophils and an endoscopy reveals atrophic gastritis. Which of the following conditions is likely to be seen in this patient? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2486485",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669681,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Vitamin B12 deficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given findings are suggestive of pernicious anemia, which is associated with atrophic gastritis and vitamin B12 deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral smear showing macrocytic RBCs and hypersegmented neutrophils are characteristic features of megaloblastic anemia. Vitamin B12 and folic acid deficiency are the classic causes of megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/hypersegmented-neutrophil_Hat7mmI.jpg\" style=\"height:262px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pernicious anemia is a type of megaloblastic anemia caused by autoimmune gastritis and an inability to produce intrinsic factors, resulting in vitamin B12 deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histologically, there is chronic atrophic gastritis with parietal cell loss, a prominent infiltrate of lymphocytes and plasma cells, and megaloblastic changes in mucosal cells similar to those seen in erythroid precursors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are <strong>three types of autoantibodies namely, type I, II, and III</strong>. The action of each of these include:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autoantibody <strong>type I</strong> prevents the binding of vitamin B12 to the <strong>intrinsic factor (IF</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autoantibody <strong>type II</strong> prevents the binding of vitamin B12-IF complex to the <strong>ileal receptors.</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Autoantibody <strong>type III</strong> acts against the a and B subunits of the <strong>gastric proton pump,</strong> which impairs the production of intrinsic factor.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Folate deficiency:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Folate deficiency also causes megaloblastic anemia with macrocytes and hypersegmented neutrophils but is not typically associated with atrophic gastritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate deficiency does not usually present with the same gastrointestinal symptoms (abdominal pain, nausea, vomiting) or the autoimmune component seen in pernicious anemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pyridoxine deficiency:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Pyridoxine (vitamin B6) deficiency is associated with sideroblastic anemia, not megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It does not cause macrocytic anemia or atrophic gastritis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Niacin deficiency:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Niacin (vitamin B3) deficiency causes pellagra, characterized by the &quot;4 Ds&quot;: dermatitis, diarrhea, dementia, and death.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It does not cause macrocytic anemia or atrophic gastritis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin B12 deficiency, often due to pernicious anemia, is characterized by macrocytic anemia, hypersegmented neutrophils, and atrophic gastritis. This condition involves an autoimmune mechanism that impairs the production and function of intrinsic factor, essential for vitamin B12 absorption.</span></span></span></p>",
    "correct_choice_id": 41518,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 73659,
    "choices": [
      {
        "id": 293577,
        "text": "<p><span style=\"font-size:16px;\">A-3, B-1, C-2, D-4</span></p>"
      },
      {
        "id": 293578,
        "text": "<p><span style=\"font-size:16px;\">A-4, B-2, C-1, D-3</span></p>"
      },
      {
        "id": 293579,
        "text": "<p><span style=\"font-size:16px;\">A-1, B-4, C-3, D-2</span></p>"
      },
      {
        "id": 293580,
        "text": "<p><span style=\"font-size:16px;\">A-2, B- 3, C-4, D-1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following:</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ohnoc8c.png\" width=\"962\" height=\"259\"></span></p>",
    "unique_key": "Q1693864",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669217,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) A-2, B-3, C-4, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;The correct matching is:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein (AFP)</strong> is a major tumor marker for <strong>hepatocellular carcinoma</strong>. It's an oncofetal protein that is normally produced during fetal development but can be elevated in certain cancers, particularly hepatocellular carcinoma.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Beta-hCG (human chorionic gonadotropin)</strong> is the primary tumor marker for <strong>choriocarcinoma.</strong> This marker is normally produced during pregnancy but is pathologically elevated in choriocarcinoma, a malignant trophoblastic tumor.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Catecholamines</strong> (epinephrine, norepinephrine, dopamine) are elevated in <strong>pheochromocytoma,</strong> which is a tumor of the adrenal medulla that secretes excessive amounts of these hormones.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Calcitonin</strong> is the characteristic tumor marker for <strong>medullary thyroid carcinoma,</strong> which arises from parafollicular C cells of the thyroid gland that produce this hormone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tumor Markers</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-05%20125042.jpg\" width=\"1077\" height=\"299\"></p>",
    "correct_choice_id": 293580,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73654,
    "choices": [
      {
        "id": 293557,
        "text": "<p><span style=\"font-size:16px;\">Platelet</span></p>"
      },
      {
        "id": 293558,
        "text": "<p><span style=\"font-size:16px;\">RBC</span></p>"
      },
      {
        "id": 293559,
        "text": "<p><span style=\"font-size:16px;\">Serum albumin</span></p>"
      },
      {
        "id": 293560,
        "text": "<p><span style=\"font-size:16px;\">Cryoprecipitate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All blood products are separated by Centrifugation except:</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2024)</span></p>",
    "unique_key": "Q2038037",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669490,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Serum albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most blood components are separated using <strong>centrifugation</strong>, which involves different speeds:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Low-speed centrifugation</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Separates <strong>Packed RBCs</strong> from <strong>platelet-rich plasma (PRP)</strong>.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>High-speed centrifugation</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Separates <strong>platelets</strong> from <strong>plasma</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Plasma is further processed into <strong>Fresh Frozen Plasma (FFP)</strong>.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Cryoprecipitate Preparation</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>FFP is thawed at 1-6\u00b0C</strong>, allowing <strong>cryoprecipitate</strong> to form, which contains <strong>Factor VIII, fibrinogen, vWF, and Factor XIII</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, <strong>platelets, RBCs and cryoprecipitate are all separated using centrifugation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serum albumin, however, is obtained through a process called <strong>fractionation</strong>, not centrifugation. This involves:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Cold ethanol precipitation (Cohn\u2019s method)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Ultrafiltration and chromatography techniques</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Centrifugation is used to separate RBCs, platelets, and plasma-derived components like cryoprecipitate. <strong>Serum albumin, however, is obtained through fractionation, making it the correct answer.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BqehzDt.png\" width=\"921\" height=\"632\"></strong></span></p>",
    "correct_choice_id": 293559,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10125,
    "choices": [
      {
        "id": 40466,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Extrinsic</span></span></span></p>"
      },
      {
        "id": 40467,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrinsic</span></span></span></p>"
      },
      {
        "id": 40468,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibrinolysis</span></span></span></p>"
      },
      {
        "id": 40469,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Common</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When you add calcium and thromboplastin to platelet poor plasma which pathway is assessed?</span></span> (AIIMS MAY 2017)</p>",
    "unique_key": "Q2663256",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669690,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Extrinsic </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thromboplastin (Factor III) binds with Factor VII. When calcium is added, it activates extrinsic pathway. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-370.jpg\" style=\"height:500px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activated Prothrombin Time (aPTT) measures the integrity of the intrinsic system (Factors XII, XI, VIII, IX) and common clotting pathways. Calcium and activating substances (kaolin) are added to the plasma- </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-371.jpg\" style=\"height:500px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Intrinsic:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The intrinsic pathway is assessed using the <strong>Activated Partial Thromboplastin Time (aPTT)</strong> test, where calcium and an activating substance like kaolin (not thromboplastin) are added to the plasma to measure the activity of Factors XII, XI, IX, and VIII.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fibrinolysis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Fibrinolysis is the process of breaking down fibrin clots, which is not directly assessed by adding thromboplastin and calcium. It is evaluated by other means, such as measuring fibrin degradation products (FDPs) or D-dimer levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Common:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While the extrinsic pathway feeds into the common pathway (Factors X, V, II, and I), the specific test described (PT) is primarily assessing the extrinsic pathway, though it also gives some information about the common pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adding calcium and thromboplastin to platelet-poor plasma assesses the extrinsic pathway of coagulation, which is the basis for the Prothrombin Time (PT) test.</span></span></span></p>",
    "correct_choice_id": 40466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 43906,
    "choices": [
      {
        "id": 175287,
        "text": "<p><span style=\"font-size:12.0pt;\">Trisodium Citrate</span></p>"
      },
      {
        "id": 175288,
        "text": "<p><span style=\"font-size:12.0pt;\">Potassium oxalate</span></p>"
      },
      {
        "id": 175289,
        "text": "<p><span style=\"font-size:12.0pt;\">Sodium fluoride</span></p>"
      },
      {
        "id": 175290,
        "text": "<p><span style=\"font-size:12.0pt;\">EDTA</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A physician wanted to perform plasma glucose estimation using the vacutainer shown in the image. Which of the following is the anticoagulant used for this test?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151112.JPG\" alt=\"\" width=\"200\" height=\"290\"></span></p>",
    "unique_key": "Q2601970",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669686,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Potassium oxalate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Potassium oxalate is commonly used in vacutainers for plasma glucose estimation because it acts as both an anticoagulant and it prevents clotting by binding calcium in the blood. We presume that the examiner by mistake showed the blue topped vacutainer in place of the gray one. However let us review that blue-topped vacutainer contains Trisodium citrate while the gray-topped vacutainer contains Potassium oxalate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trisodium Citrate:&nbsp;</strong>Used primarily as an anticoagulant in blood collection tubes for coagulation studies, not suitable for glucose estimation because it does not prevent glycolysis effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sodium fluoride:&nbsp;</strong>Also a glycolysis inhibitor and commonly used with an anticoagulant (potassium oxalate) in glucose testing..</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EDTA:&nbsp;</strong>Mainly used as an anticoagulant in hematology tests. While it effectively prevents blood clots, it does not inhibit glycolysis, making it unsuitable for glucose tests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">For accurate plasma glucose estimation, potassium oxalate and enolase is used because it effectively prevents blood clotting and preserves glucose by inhibiting glycolysis respectively.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Always use a grey-top tube (NaF/KOx) when measuring plasma glucose to prevent post-collection glycolysis and falsely low results.</span></p>",
    "correct_choice_id": 175288,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 9806,
    "choices": [
      {
        "id": 39191,
        "text": "<p><span style=\"font-size:12.0pt;\">O</span></p>"
      },
      {
        "id": 39192,
        "text": "<p><span style=\"font-size:12.0pt;\">AB</span></p>"
      },
      {
        "id": 39193,
        "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
      },
      {
        "id": 39194,
        "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has been brought with severe bleeding to your ER. His blood group is unknown. Fresh frozen plasma from which of the following blood groups can be given? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q2556086",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669684,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) AB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FFP from AB blood group can be given to this patient since the universal plasma donor is AB<strong>. AB plasma does not contain antibodies against antigens on RBCs of AB blood group.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, the question is about fresh frozen plasma transfusion and not about the packed red cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Had the question been about packed RBCs then in case of<strong> emergency packed cell blood transfusion with unknown blood group, O Rh-negative blood</strong> <strong>(universal donor) is transfused.</strong> It is preferred because it lacks the A and B and Rh antigens. Hence, it cannot be hemolyzed by anti-A, anti-B or anti-D antibodies in the recipient's blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104002.png\" alt=\"\" width=\"1000\" height=\"917\"></p>",
    "correct_choice_id": 39192,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 10487,
    "choices": [
      {
        "id": 41914,
        "text": "<p><span style=\"font-size:12.0pt;\">Endo-myocardial biopsy</span></p>"
      },
      {
        "id": 41915,
        "text": "<p><span style=\"font-size:12.0pt;\">Magnetic Resonance Imaging</span></p>"
      },
      {
        "id": 41916,
        "text": "<p><span style=\"font-size:12.0pt;\">Brain Natriuretic Peptide</span></p>"
      },
      {
        "id": 41917,
        "text": "<p><span style=\"font-size:12.0pt;\">LDH1 to LDH2 ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the gold standard investigation for the diagnosis of myocarditis? (AIIMS NOV 2021)</span></p>",
    "unique_key": "Q2893252",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669701,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Endo-myocardial biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>An endo-myocardial biopsy is the gold standard investigation for the diagnosis of myocarditis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Active myocarditis is characterized by an interstitial inflammatory infiltrate associated with degenerating or apoptotic myocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Etiological classification of myocarditis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-112101.png\" alt=\"\" width=\"1000\" height=\"569\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Magnetic Resonance Imaging:</strong> MRI can be used to detect myocardial inflammation and scarring, but it is not the gold standard. It is useful for non-invasive assessment but cannot definitively diagnose myocarditis without histological confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Brain Natriuretic Peptide (BNP):</strong> BNP is a biomarker used to assess heart failure but is not specific or sensitive for diagnosing myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. LDH1 to LDH2 ratio:</strong> This ratio is sometimes used in the context of myocardial infarction but does not have a role in diagnosing myocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Endo-myocardial biopsy&nbsp;</strong>remains the gold standard for diagnosing myocarditis, as it allows for direct histopathological examination of myocardial tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 1064</strong></span></p>",
    "correct_choice_id": 41914,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 9835,
    "choices": [
      {
        "id": 39307,
        "text": "<p><span style=\"font-size:12.0pt;\">Lipids without MHC proteins</span></p>"
      },
      {
        "id": 39308,
        "text": "<p><span style=\"font-size:12.0pt;\">Peptides with MHC proteins</span></p>"
      },
      {
        "id": 39309,
        "text": "<p><span style=\"font-size:12.0pt;\">CD20</span></p>"
      },
      {
        "id": 39310,
        "text": "<p><span style=\"font-size:12.0pt;\">CD3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Gamma delta T cell receptors (\u03b3\u03b4 TCRs) recognizes? </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q2851723",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669697,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>A) Lipids without MHC proteins</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A small population of mature T cells expresses a type of TCR composed of \u03b3 and \u03b4 polypeptide chains. <strong>The \u03b3\u03b4 TCR recognizes peptides, lipids, and small molecules, without a requirement for display by MHC proteins</strong>. \u03b3\u03b4 T cells tend to aggregate at epithelial surfaces, such as the skin and mucosa of the gastrointestinal and urogenital tracts, suggesting that these cells are sentinels that protect against microbes that try to enter through epithelia</span></li><li><span style=\"font-size:12.0pt;\"><strong>The \u03b1\u03b2 TCR recognizes peptide antigens that are displayed by major histocompatibility complex (MHC. molecules on the surfaces of antigen-presenting cells (APCs).</strong> By limiting the specificity of T cells for peptides displayed by cell surface MHC molecules, <strong>called MHC restriction</strong>, the immune system ensures that T cells see only cell-associated antigens (e.g., those derived from microbes in cells).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Peptides with MHC proteins</strong>: This is characteristic of <strong>\u03b1\u03b2 TCRs</strong>, not \u03b3\u03b4 TCRs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD20</strong>: CD20 is a B cell marker, not a target recognized by T cell receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CD3</strong>: CD3 is a signaling molecule associated with the T cell receptor complex but is not a specific target recognized by the TCR itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gamma delta T cell receptors (\u03b3\u03b4 TCRs)&nbsp;</strong>are unique in that they can recognize <strong>lipids and other molecules without the need for MHC protein presentation</strong>, distinguishing them from the more common \u03b1\u03b2 T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease 8th edition pg 353</strong></span></p>",
    "correct_choice_id": 39307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 54506,
    "choices": [
      {
        "id": 217493,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic venous insufficiency</span></p>"
      },
      {
        "id": 217494,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic renal failure</span></p>"
      },
      {
        "id": 217495,
        "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
      },
      {
        "id": 217496,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic liver disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Bilateral pedal edema is least likely to be associated with which of the following?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q2216882",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669553,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chronic venous insufficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bilateral pedal edema is often due to systemic conditions that lead to fluid retention or increased pressure in the veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chronic venous insufficiency</strong>, typically results from conditions like deep vein thrombosis (DVT), which is more likely to cause unilateral (one-sided) pedal edema due to localized obstruction of venous return. While chronic venous insufficiency can sometimes cause bilateral edema, it is less common compared to the other conditions listed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chronic renal failure:</strong> Patients with chronic renal failure cannot excrete excess fluid properly, leading to fluid retention and generalized edema, including in both legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congestive heart failure:</strong> Heart failure results in increased venous pressure and fluid retention, which typically causes dependent edema, including bilateral pedal edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic liver disease:</strong> Liver disease can lead to hypoalbuminemia and reduced oncotic pressure, causing generalized and bilateral pedal edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic venous insufficiency is least likely to be associated with bilateral pedal edema compared to chronic renal failure, congestive heart failure, and chronic liver disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Edema results from imbalances in:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Hydrostatic pressure</strong> (\u2191 in heart failure)</span></li><li><span style=\"font-size:16px;\"><strong>Oncotic pressure</strong> (\u2193 in liver/kidney disease)</span></li><li><span style=\"font-size:16px;\"><strong>Lymphatic drainage</strong></span></li><li><span style=\"font-size:16px;\"><strong>Capillary permeability</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6PG9POy.png\" width=\"1116\" height=\"361\"></span></p>",
    "correct_choice_id": 217493,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10374,
    "choices": [
      {
        "id": 41462,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lead poisoning</span></span></span></p>"
      },
      {
        "id": 41463,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron deficiency anemia</span></span></span></p>"
      },
      {
        "id": 41464,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemolytic anemia</span></span></span></p>"
      },
      {
        "id": 41465,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholism</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old male patient presented with a history of fatigue and tiredness. On investigation, he was found to have Hb = 9 gm% and MCV =101 FL. Peripheral smear examination showed macrocytic RBC and hyper-segmented neutrophils. Which of the following is the most likely etiology? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q2386185",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669677,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Chronic alcoholism </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given findings are suggestive of macrocytic anemia, which can be seen in chronic alcoholics.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Peripheral smear showing macrocytic RBCs and hyper-segmented neutrophils are characteristic features of megaloblastic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/hypersegmented-neutrophil.jpg\" style=\"height:262px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholics also have deficiency of folic acid due to:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folate accumulation in the liver </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Excessive urinary loss </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Impaired folate metabolism</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic alcoholics frequently have insufficient dietary intake.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Lead poisoning:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lead poisoning typically causes microcytic anemia rather than macrocytic anemia. Peripheral smear findings in lead poisoning include basophilic stippling of RBCs, not macrocytic RBCs and hyper-segmented neutrophils.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Iron deficiency anemia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iron deficiency anemia is characterized by microcytic, hypochromic RBCs, which contrasts with the macrocytic RBCs and hyper-segmented neutrophils seen in this patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hemolytic anemia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hemolytic anemia generally presents with normocytic or slightly macrocytic RBCs, but not to the extent seen in megaloblastic anemia. Additionally, hyper-segmented neutrophils are not a typical feature of hemolytic anemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Macrocytic anemia with hyper-segmented neutrophils on a peripheral smear is characteristic of megaloblastic anemia, often due to folate deficiency, which is commonly seen in chronic alcoholics due to impaired folate metabolism and poor dietary intake.</span></span></span></p>",
    "correct_choice_id": 41465,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 9833,
    "choices": [
      {
        "id": 39299,
        "text": "<p><span style=\"font-size:12.0pt;\">Lymphocyte</span></p>"
      },
      {
        "id": 39300,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibroblast</span></p>"
      },
      {
        "id": 39301,
        "text": "<p><span style=\"font-size:12.0pt;\">Macrophage</span></p>"
      },
      {
        "id": 39302,
        "text": "<p><span style=\"font-size:12.0pt;\">Mast Cell</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Toluidine blue staining is used in the Identification of which of the following cells? </span>(AIIMS MAY 2018)</p>",
    "unique_key": "Q2433591",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669680,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mast Cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Toluidine blue is the special stain for mast cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Toluidine blue (also known as tolonium chloride) is an acidophilic metachromatic dye that selectively stains acidic tissue components (sulfates, carboxylates, and phosphate radicals). <strong>Toluidine blue (TB. has an affinity for nucleic acids, and therefore binds to nuclear material of tissues with a high DNA and RNA content.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It also intensely stains some substances leading to a change in color. This effect known as metachromasia.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthochromatic Staining</strong> - structures stained blue (Lymphocytes)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metachromatic Staining</strong> - structures stained dark purple from polymeric aggregates formed when binding to high concentrations of polyanions (Mast cells)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue is often used to identify mast cells by virtue of heparin</strong> (which is very polyanionic. found in their secretion granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/960.jpg\" alt=\"\" width=\"677\" height=\"303\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Application of Toluidine Blue</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Connective tissue mucins, especially acid mucins. The tissue stains purple to red, while the background is stained blue.</span></li><li><span style=\"font-size:12.0pt;\">Mast cell granules stain purple in color due to the presence of heparin and histamine.</span></li><li><span style=\"font-size:12.0pt;\">Amyloid stain blue but under polarized light they give a bright red birefringence.</span></li><li><span style=\"font-size:12.0pt;\">Endocrine cell granules are stained purple to red.</span></li><li><span style=\"font-size:12.0pt;\">Sulfatides stain red brown or yellow. Only lipids that are sufficiently acidic to induce a metachromatic shift are stained.</span></li><li><span style=\"font-size:12.0pt;\">Corynebacterium diphtheria contains granules with polymerized inorganic polyphosphate, which stains red violet color.</span></li><li><span style=\"font-size:12.0pt;\">Helicobacter stains dark blue against a variably blue background.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lymphocyte</strong>: Lymphocytes can be stained with toluidine blue, but they show orthochromatic staining (blue), not the metachromasia that is characteristic of mast cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fibroblast</strong>: Fibroblasts are not specifically identified by toluidine blue staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Macrophage</strong>: While macrophages can be stained with various dyes, they do not exhibit the metachromasia seen in mast cells with toluidine blue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Toluidine blue&nbsp;</strong>is primarily used to identify <strong>mast cells</strong> due to their characteristic <strong>metachromatic staining</strong> caused by the heparin in their granules.</span></p>",
    "correct_choice_id": 39302,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "InvestigationBased"
    ]
  },
  {
    "id": 10400,
    "choices": [
      {
        "id": 41566,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Dysplasia</span></span></span></span></p>"
      },
      {
        "id": 41567,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hypertrophy</span></span></span></span></p>"
      },
      {
        "id": 41568,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Atrophy</span></span></span></span></p>"
      },
      {
        "id": 41569,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Metaplasia</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged man with a long history of chronic smoking presents to the clinic with respiratory symptoms. Upon examination, it is noted that the lining epithelium of his respiratory tract has undergone a notable change. The transition from columnar epithelium to stratified squamous epithelium is evident, as depicted in the provided image. To identify this specific change, what is the term used to describe this alteration in the lining epithelium? (NEET PG 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-144444.png\" style=\"height:168px; width:500px\" /></p>",
    "unique_key": "Q1380598",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669210,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Metaplasia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The change described in the question is called metaplasia. It is defined as a reversible change in which one type of differentiated cell is replaced by another type.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/44_bWijTwu.jpg\" style=\"height:175px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/45_5UCYsQ1.jpg\" style=\"height:126px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metaplasia of normal columnar (left) to squamous epithelium (right) in a bronchus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Another example of metaplasia: BARRETTs esophagus</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/46_Dnrkevr.jpg\" style=\"height:275px; width:413px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dysplasia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Dysplasia refers to abnormal development or growth of cells, tissues, or organs. It is characterized by changes in cell size, shape, and organization. Dysplasia can be a precursor to cancer but does not describe the replacement of one cell type by another.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypertrophy:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hypertrophy is the increase in the size of cells, leading to an increase in the size of the tissue or organ. It does not involve a change in the cell type.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Atrophy:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Atrophy refers to the reduction in the size of cells, tissues, or organs, often due to decreased use, insufficient nutrition, or aging. It does not involve a change in the cell type.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metaplasia is the term used to describe the reversible change where one type of differentiated cell is replaced by another type, often as an adaptive response to chronic irritation or inflammation, such as the transition from columnar to squamous epithelium in the respiratory tract of chronic smokers.</span></span></span></p>",
    "correct_choice_id": 41569,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 21442,
    "choices": [
      {
        "id": 85732,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepatocellular cancer</span></p>"
      },
      {
        "id": 85733,
        "text": "<p><span style=\"font-size:12.0pt;\">Cholangiocarcinoma</span></p>"
      },
      {
        "id": 85734,
        "text": "<p><span style=\"font-size:12.0pt;\">Gastric cancer&nbsp;</span></p>"
      },
      {
        "id": 85735,
        "text": "<p><span style=\"font-size:12.0pt;\">Urinary bladder cancer</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Clonorchis sinensis is associated with which type of cancer? (NEET PG 2023)</span></p>",
    "unique_key": "Q1344571",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669208,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cholangiocarcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clonorchis sinensis, also known as the Chinese liver fluke, is a parasitic worm that infects the bile ducts of the liver. Chronic infection with Clonorchis sinensis is a well-known risk factor for the development of cholangiocarcinoma, which is a type of cancer that occurs in the bile ducts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatocellular cancer:&nbsp;</strong>This is commonly associated with chronic hepatitis B and C infections, cirrhosis, and aflatoxin exposure, not typically with Clonorchis sinensis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gastric cancer:&nbsp;</strong>Associated with Helicobacter pylori infection, dietary factors, and genetic predisposition, not with Clonorchis sinensis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urinary bladder cancer:&nbsp;</strong>Often linked to smoking, occupational exposures, and Schistosoma haematobium infection (another type of parasitic worm), not Clonorchis sinensis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Opisthorchis viverrini is the new name of Clonorchis sinensis. It is associated with cholangiocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Humans acquire the infection by eating raw or undercooked freshwater fish containing the metacercariae (infective stage).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic infection leads to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Inflammation</span></li><li><span style=\"font-size:12.0pt;\">Hyperplasia of the biliary epithelium</span></li><li><span style=\"font-size:12.0pt;\">Fibrosis</span></li><li><span style=\"font-size:12.0pt;\">Malignant transformation \u2192 Cholangiocarcinoma</span></li></ul>",
    "correct_choice_id": 85733,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 24736,
    "choices": [
      {
        "id": 98905,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor V Leiden mutation</span></span></span></p>"
      },
      {
        "id": 98906,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protein C deficiency</span></span></span></p>"
      },
      {
        "id": 98907,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antithrombin III deficiency</span></span></span></p>"
      },
      {
        "id": 98908,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G20210A prothrombin gene mutation</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common genetic factor responsible for hypercoagulability?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q2195175",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669549,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Factor V Leiden mutation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Factor V Leiden mutation (Activated protein C resistance) is the most common inherited disorder that causes hypercoagulability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The&nbsp;prothrombin G20210A mutation&nbsp;is the second most common inherited risk factor for thrombosis and leads to increased levels of prothrombin which&nbsp;demonstrates&nbsp;a higher risk for arterial and venous thrombotic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protein C &amp; S deficiency, Antithrombin III deficiency, Hyperhomocysteinemia, Elevated factor VIII (FVIII) are other causes of hypercoagulability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Protein C deficiency</span></strong><span style=\"font-size:12.0pt\">: Protein C deficiency is a rarer inherited condition that also increases the risk of venous thromboembolism due to impaired inactivation of Factors Va and VIIIa. However, it is less common than Factor V Leiden mutation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Antithrombin III deficiency</span></strong><span style=\"font-size:12.0pt\">: This is another inherited disorder leading to hypercoagulability. Antithrombin III normally inhibits thrombin and other clotting factors, and its deficiency increases the risk of thrombosis. Again, it is less common than Factor V Leiden mutation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. G20210A prothrombin gene mutation</span></strong><span style=\"font-size:12.0pt\">: This mutation is the second most common inherited risk factor for thrombosis. It leads to increased levels of prothrombin, which is associated with a higher risk for both arterial and venous thrombotic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Factor V Leiden mutation is the most common inherited cause of hypercoagulability, primarily due to resistance to Activated Protein C.</span></span></span></p>",
    "correct_choice_id": 98905,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10064,
    "choices": [
      {
        "id": 40222,
        "text": "<p><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma</span></p>"
      },
      {
        "id": 40223,
        "text": "<p><span style=\"font-size:12.0pt;\">Pituitary adenoma</span></p>"
      },
      {
        "id": 40224,
        "text": "<p><span style=\"font-size:12.0pt;\">Paraganglioma</span></p>"
      },
      {
        "id": 40225,
        "text": "<p><span style=\"font-size:12.0pt;\">Adrenal cortical tumor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All of the following conditions are associated with Neurosecretory bodies except:</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p>",
    "unique_key": "Q2493004",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669682,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Adrenal cortical tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Neurosecretory bodies are not seen in adrenal cortical tumors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adrenocortical neoplasms produce aldosterone. Primary hyperaldosteronism due to a solitary aldosterone-secreting adenoma is Conn syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Microscopically, aldosterone-producing adenomas show <strong>spironolactone bodies</strong> which are eosinophilic, laminated cytoplasmic inclusions found after treatment with spironolactone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1.jpg\" alt=\"\" width=\"400\" height=\"298\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Medullary thyroid carcinoma</strong>:<strong> </strong>Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from parafollicular C-cells, which are neuroendocrine cells. These cells secrete calcitonin and often contain neurosecretory granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pituitary adenoma</strong>:<strong> </strong>Pituitary adenomas are tumors of the pituitary gland, many of which are neuroendocrine in nature. They can produce hormones such as prolactin, growth hormone, or ACTH, and neurosecretory granules can be found in these tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Paraganglioma</strong>: Paragangliomas are tumors that arise from paraganglia, which are collections of neuroendocrine cells. These cells are closely related to the sympathetic and parasympathetic nervous systems and often contain neurosecretory granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neurosecretory bodies are associated with neuroendocrine tumors, but not with adrenal cortical tumors, which originate from the adrenal cortex and are involved in steroid hormone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tumors associated with neurosecretory granules</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZganjU0.png\" width=\"1074\" height=\"874\"></span></p>",
    "correct_choice_id": 40225,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 10022,
    "choices": [
      {
        "id": 40054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute lymphoblastic leukemia</span></span></span></p>"
      },
      {
        "id": 40055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic lymphocytic leukemia</span></span></span></p>"
      },
      {
        "id": 40056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute myeloid leukemia</span></span></span></p>"
      },
      {
        "id": 40057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic myelogenous leukemia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given peripheral smear is associated with which of the following leukemias? (INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2.jpg\" style=\"height:209px; width:300px\" /></p>",
    "unique_key": "Q2958277",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669702,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Chronic lymphocytic leukemia</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The peripheral smear findings point toward a diagnosis of chronic lymphocytic leukemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The blood contains large numbers of small round lymphocytes with scant cytoplasm. Some of these cells are usually disrupted in the process of making smears, producing <strong>so-called smudge cells</strong>. Lymphocytes are of same size and configuration with a uniform appearance <strong>called as &quot;convent-girl&quot; appearance.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Acute lymphoblastic leukemia (ALL)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in ALL typically shows a high number of lymphoblasts, which are larger than normal lymphocytes and have a high nuclear-cytoplasmic ratio. There would be an absence of smudge cells, which are characteristic of CLL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Acute myeloid leukemia (AML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: AML is characterized by the presence of myeloblasts in the peripheral blood smear. These cells are larger, have more cytoplasm, and may contain Auer rods. Again, smudge cells are not a feature of AML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Chronic myelogenous leukemia (CML)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The peripheral smear in CML shows a full spectrum of myeloid cells, from myeloblasts to mature neutrophils, often with an increase in basophils and eosinophils. Smudge cells are not a characteristic finding in CML.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-122634_v2GVwX7.jpg\" style=\"height:370px; width:1000px\" /></strong></span></span></span></p>",
    "correct_choice_id": 40055,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 9961,
    "choices": [
      {
        "id": 39810,
        "text": "<p><span style=\"font-size:12.0pt;\">Renal amyloidosis</span></p>"
      },
      {
        "id": 39811,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal segmental glomerulosclerosis</span></p>"
      },
      {
        "id": 39812,
        "text": "<p><span style=\"font-size:12.0pt;\">Kimmelstiel-Wilson disease</span></p>"
      },
      {
        "id": 39813,
        "text": "<p><span style=\"font-size:12.0pt;\">Lupus nephritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man presented with the blurring of vision. Urine examination showed proteinuria. Fundus examination showed dot and blot hemorrhages, microaneurysms, and cotton wool spots. Histopathology of the kidney was as shown below. What is your diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/31.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p>",
    "unique_key": "Q1136043",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669185,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Kimmelstiel-Wilson disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histopathological image shows <strong>acellular periodic acid Schiff (PAS)-positive nodules</strong> suggestive of nodular glomerulosclerosis/intercapillary glomerulosclerosis seen in <strong>Kimmelstiel Wilson disease,</strong> which occurs in patients with diabetic nephropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These lesions are <strong>specific for type 1 diabetes</strong> (juvenile onset diabetes) or islet cell antibody-positive diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pathologic changes consist of one or more nodules in a few or many glomeruli. Nodule is an ovoid or spherical, laminated, hyaline, acellular mass located within a lobule of the glomerulus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The nodules are surrounded peripherally by glomerular capillary loops which may have normal or thickened GBM. The nodules <strong>are PAS-positive and contain lipid and fibrin. </strong>These nodular lesions are frequently accompanied by prominent accumulations of hyaline material in capillary loops (\u201c<strong>fibrin caps</strong>\u201d) or adherent to Bowman's capsules (\u201c<strong>capsular drops</strong>\u201d).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/32.jpg\" alt=\"\" width=\"677\" height=\"313\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the nodular lesions enlarge, <strong>they compress the glomerular capillaries</strong> and obliterate the glomerular tuft. As a result of glomerular and arteriolar involvement, <strong>renal ischemia</strong> occurs leading to tubular atrophy and interstitial fibrosis and <strong>grossly small, contracted kidney</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Renal failure is the second common cause of death in diabetes mellitus, the first being myocardial infarction.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic nephropathy encompasses 4 types of renal lesions in diabetes mellitus:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Diabetic glomerulosclerosis (Diffuse/ Nodular)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Diffuse lesions</strong> are characterized by diffuse involvement of the glomeruli showing thickening of the GBM and diffuse increase in the mesangial matrix with mild proliferation of mesangial cells and exudative lesions (fibrin caps and capsular drops)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Nodular lesion (Kimmelstiel-Wilson Lesion)&nbsp;</strong>is characterized by one or more hyaline nodules within the lobules of glomeruli, surrounded peripherally by glomerular capillaries with thickened walls.</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/33.jpg\" alt=\"\" width=\"619\" height=\"460\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2.&nbsp; Vascular lesions \u2013 <strong>Hyaline arterioslerosis</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Morphology</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/34.jpg\" alt=\"\" width=\"635\" height=\"283\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. Diabetic pyelonephritis \u2013 <strong>Papillary necrosis</strong> / Necrotizing papillitis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Tubular lesions (Armanni-Ebstein lesions</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/41.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Renal amyloidosis:</strong> Amyloidosis presents with amyloid deposits, typically visualized using Congo red stain, which is different from the PAS-positive nodules seen in Kimmelstiel-Wilson disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Focal segmental glomerulosclerosis (FSGS):</strong> FSGS is characterized by segmental scarring of some glomeruli and does not present with the diffuse nodular glomerulosclerosis observed in Kimmelstiel-Wilson disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Lupus nephritis:</strong> Lupus nephritis involves immune complex deposition, which leads to a different set of histological changes, including \"wire loop\" lesions, which are not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kimmelstiel-Wilson disease, a specific form of diabetic nephropathy, is characterized by PAS-positive nodules within the glomeruli, often associated with type 1 diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbin and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Page No. 2206</strong></span></p>",
    "correct_choice_id": 39812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ]
  },
  {
    "id": 9779,
    "choices": [
      {
        "id": 39083,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dystrophic with increased serum calcium</span></span></span></p>"
      },
      {
        "id": 39084,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic with increased serum calcium</span></span></span></p>"
      },
      {
        "id": 39085,
        "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dystrophic with normal serum calcium</span></span></span></p>"
      },
      {
        "id": 39086,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastatic with normal serum calcium</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 58-year-old man died 24 hours after the onset of substernal chest pain radiating to the left arm. On autopsy, an atheromatous plaque was seen obstructing the left anterior descending artery. Which type of calcification is most likely to be seen in this condition?</span> </span></span>(AIIMS MAY 2019)</p>",
    "unique_key": "Q2999498",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669703,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Dystrophic with normal serum calcium</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atheromatous plaques show dystrophic calcification in the presence of normal calcium levels in the serum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The deposition of calcium in dead or dying tissues is called dystrophic calcification. Although it occurs in the presence of normal serum calcium, it can be worsened by hypercalcemia.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dystrophic calcification is seen in areas of necrosis of any type - </span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in dead tissue &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caseous necrosis in tuberculosis is the most common site for dystrophic calcification. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liquefaction necrosis in chronic abscesses may get calcified.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fat necrosis following acute pancreatitis or traumatic fat necrosis in the breast results in deposition of calcium soaps.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gamma-Gandy bodies</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> in chronic venous congestion (CVC. of the spleen is characterized by calcific deposits admixed with hemosiderin on fibrous tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infarcts may sometimes undergo dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombi, especially in the veins, may produce phleboliths.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hematomas in the vicinity of bones may undergo dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dead parasites like in hydatid cyst, Schistosoma eggs, and cysticercosis are some of the examples showing dystrophic calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in breast cancer detected by mammography.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Congenital toxoplasmosis involving the central nervous system visualized by calcification in the infant brain.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcification in degenerated tissues</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dense old scars may undergo hyaline degeneration and subsequent calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atheromatous in the aorta and coronaries frequently undergo calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M&ouml;nckeberg&rsquo;s sclerosis shows calcification in the tunica media of muscular arteries in elderly people </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stroma of tumors such as uterine fibroids, breast cancer, thyroid adenoma, goitre etc. show calcification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Some tumors show characteristic spherules of calcification called psammoma bodies or calcospherites such as in meningioma, papillary serous cystadenocarcinoma of the ovary and papillary carcinoma of the thyroid.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cysts which have been present for a long time may show calcification of their walls e.g. epidermal and pilar cysts.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcinosis cutis is a condition of unknown cause in which there are irregular nodular deposits of calcium salts in the skin and subcutaneous tissue.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Senile degenerative changes may be accompanied by dystrophic calcification such as in costal cartilages, tracheal or bronchial cartilages, and pineal gland in the brain etc.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Dystrophic with increased serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Dystrophic calcification typically occurs in the setting of normal serum calcium levels. While hypercalcemia can exacerbate dystrophic calcification, it is not a defining feature.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Metastatic with increased serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Metastatic calcification occurs when calcium salts are deposited in normal tissues as a result of hypercalcemia. This form of calcification is not associated with tissue injury or necrosis and typically affects tissues like the lungs, stomach, kidneys, and blood vessels under conditions of high serum calcium. It does not apply to the situation described, where calcification is occurring in damaged tissue with normal calcium levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Metastatic with normal serum calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This option is incorrect because metastatic calcification is always associated with hypercalcemia, not normal serum calcium levels.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-113716.png\" style=\"height:289px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran pathologic basis of disease, 8<sup>th</sup> edition, Pg no 83</span></strong></span></span></p>",
    "correct_choice_id": 39085,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 10085,
    "choices": [
      {
        "id": 40306,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cadherins</span></span></span></p>"
      },
      {
        "id": 40307,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Platelet endothelial cell adhesion molecule-1 (PECAM-1)</span></span></span></p>"
      },
      {
        "id": 40308,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E-selectin</span></span></span></p>"
      },
      {
        "id": 40309,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cd11a</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following molecules are involved in helping the leukocytes to roll over the endothelial cells in the vessels?</span></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET MAY 2022)</span></span></p>",
    "unique_key": "Q1986356",
    "question_audio": null,
    "question_video": null,
    "map_id": 34669486,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) E-selectin</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E-selectins are involved in rolling of leucocytes over endothelial cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cellular Changes during Inflammation</span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-153326.jpg\" style=\"height:637px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture16.jpg\" style=\"height:218px; width:700px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-64px; text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cadherins:</span></strong><span style=\"font-size:12.0pt\"> These are involved in cell-cell adhesion in various tissues but are not specifically involved in the rolling of leukocytes during inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. PECAM-1 (Platelet endothelial cell adhesion molecule-1):</span></strong><span style=\"font-size:12.0pt\"> PECAM-1 is primarily involved in the process of diapedesis, where leukocytes transmigrate across the endothelium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. CD11a:</span></strong><span style=\"font-size:12.0pt\"> This is an integrin (part of the LFA-1 complex) involved in the firm adhesion of leukocytes to the endothelium, not in the rolling process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">E-selectin is critical for the rolling of leukocytes along the endothelial cells during the early stages of the inflammatory response.</span></span></span></p>",
    "correct_choice_id": 40308,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  }
];
        let quizName = 'Late Night Pyq (Inicet, Pathology-1)';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>